MCID: APP003
MIFTS: 40

Appendiceal Neoplasm

Categories: Cancer diseases, Gastrointestinal diseases
Data Licensing
For inquiries, contact:

Aliases & Classifications for Appendiceal Neoplasm

Summaries for Appendiceal Neoplasm

MalaCards based summary: Appendiceal Neoplasm, also known as malignant neoplasm of appendix vermiformis, is related to appendix cancer and pseudomyxoma peritonei. An important gene associated with Appendiceal Neoplasm is SATB2 (SATB Homeobox 2), and among its related pathways/superpathways are Cell surface interactions at the vascular wall and CCR3 Pathway in Eosinophils. The drugs Durvalumab and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include appendix, small intestine and colon, and related phenotypes are Reduced mammosphere formation and neoplasm

Related Diseases for Appendiceal Neoplasm

Diseases related to Appendiceal Neoplasm via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 396, show less)
# Related Disease Score Top Affiliating Genes
1 appendix cancer 30.5 SATB2 PEX19 KRT7 KRAS HRAS GNAS
2 pseudomyxoma peritonei 29.9 KRT7 KRAS GNAS CEACAM5 CDX2
3 anal canal carcinoma 29.8 KRT7 CEACAM5 CDX2
4 cystadenoma 29.8 KRT7 GNAS CHGA CEACAM5
5 intestinal obstruction 29.8 KRT7 CEACAM5 CDX2
6 cystadenocarcinoma 29.7 KRT7 KRAS CEACAM5
7 krukenberg carcinoma 29.7 SATB2 KRT7 CEACAM5 CDX2
8 tubular adenocarcinoma 29.7 KRT7 CHGA CEACAM5 CDX2
9 rectum cancer 29.4 KRAS HRAS CEACAM5
10 ovarian cystadenocarcinoma 29.2 KRAS HRAS GNAS CEACAM5
11 colon adenocarcinoma 29.2 KRAS HRAS GNAS CEACAM5
12 intestinal benign neoplasm 29.2 KRAS HRAS CEACAM5 CDX2
13 rectal benign neoplasm 28.9 KRT7 KRAS HRAS CEACAM5 CDX2
14 mucinous adenocarcinoma 28.9 KRT7 KRAS HRAS GNAS CEACAM5 CDX2
15 anus cancer 28.8 KRT7 KRAS HRAS CEACAM5 CDX2
16 colonic benign neoplasm 28.8 KRT7 KRAS HRAS CEACAM5 CDX2
17 adenoma 28.8 KRT7 KRAS HRAS GNAS CHGA CDX2
18 colorectal adenocarcinoma 28.7 SATB2 KRT7 KRAS HRAS CEACAM5 CDX2
19 villous adenoma 28.7 KRT7 KRAS HRAS GNAS CEACAM5 CDX2
20 ovary adenocarcinoma 28.6 KRT7 KRAS HRAS GNAS CEACAM5 CDX2
21 lynch syndrome 28.5 KRT7 KRAS HRAS GNAS CEACAM5 CDX2
22 adenocarcinoma 28.5 KRT7 KRAS HRAS CHGA CEACAM5 CDX2
23 mucinous cystadenocarcinoma 28.4 MIR4328 KRT7 KRAS HRAS CEACAM5 CDX2
24 signet ring cell adenocarcinoma 28.4 KRT7 KRAS HRAS CHGA CEACAM5 CDX2
25 appendix adenocarcinoma 27.6 SATB2 PEX19 KRT7 KRAS HRAS GNAS
26 appendix carcinoid tumor 11.1
27 appendicitis 10.4
28 ovarian cyst 10.3 GNAS CEACAM5
29 mucinous cystadenocarcinoma of pancreas 10.3 SATB2 CEACAM5
30 parosteal osteosarcoma 10.3 SATB2 GNAS
31 peripheral osteosarcoma 10.3 SATB2 GNAS
32 atypical polypoid adenomyoma 10.3 SATB2 CDX2
33 laryngeal mucoepidermoid carcinoma 10.2 CEACAM5 CDX2
34 thymus adenocarcinoma 10.2 CEACAM5 CDX2
35 ovarian cystadenoma 10.2 KRT7 CEACAM5
36 carcinoid syndrome 10.2
37 goblet cell carcinoid 10.2
38 gallbladder carcinoma in situ 10.2 CEACAM5 CDX2
39 leukoplakia of penis 10.2 KRT7 CEACAM5
40 trachea carcinoma 10.2 KRT7 CEACAM5
41 urethral villous adenoma 10.2 KRT7 CEACAM5
42 bladder signet ring cell adenocarcinoma 10.2 KRT7 CDX2
43 pancreatic serous cystadenocarcinoma 10.2 KRT7 CEACAM5
44 aggressive digital papillary adenocarcinoma 10.2 KRT7 CEACAM5
45 cutaneous mucoepidermoid carcinoma 10.2 KRT7 CEACAM5
46 malignant epithelial mesothelioma 10.2 KRT7 CEACAM5
47 malignant spiradenoma 10.2 KRT7 CEACAM5
48 spiradenoma 10.2 KRT7 CEACAM5
49 eccrine porocarcinoma 10.2 KRT7 CEACAM5
50 adenosquamous bile duct carcinoma 10.2 KRT7 CEACAM5
51 ureter squamous cell carcinoma 10.2 KRT7 CEACAM5
52 apocrine adenoma 10.2 KRT7 CEACAM5
53 vulval paget's disease 10.2 KRT7 CEACAM5
54 ovary neuroendocrine neoplasm 10.2 KRT7 CDX2
55 renal pelvis adenocarcinoma 10.2 KRT7 CEACAM5
56 malignant biphasic mesothelioma 10.2 KRT7 CEACAM5
57 adenoid basal cell carcinoma 10.2 KRT7 CEACAM5
58 nodular hidradenoma 10.2 KRT7 CEACAM5
59 hidradenoma 10.2 KRT7 CEACAM5
60 vulvar apocrine adenocarcinoma 10.2 KRT7 CEACAM5
61 anal canal paget's disease 10.2 KRT7 CDX2
62 apocrine adenocarcinoma 10.2 KRT7 CEACAM5
63 seminal vesicle adenocarcinoma 10.2 KRT7 CDX2
64 malignant acrospiroma 10.2 KRT7 CEACAM5
65 anal gland adenocarcinoma 10.2 KRT7 CDX2
66 adenosquamous colon carcinoma 10.2 KRT7 CDX2
67 colonic lymphangioma 10.2 KRT7 CEACAM5
68 internal hemorrhoid 10.2 KRT7 CEACAM5
69 hemorrhoid 10.2 KRT7 CEACAM5
70 anus adenocarcinoma 10.2 KRT7 CDX2
71 eccrine adenocarcinoma 10.2 KRT7 CEACAM5
72 mucinous bronchioloalveolar adenocarcinoma 10.2 KRT7 CDX2
73 bile duct mucoepidermoid carcinoma 10.2 KRT7 CEACAM5
74 bile duct cystadenocarcinoma 10.2 KRT7 CEACAM5
75 clear cell hidradenoma 10.2 KRT7 CEACAM5
76 anal canal adenocarcinoma 10.2 KRT7 CDX2
77 jejunal adenocarcinoma 10.2 KRT7 CDX2
78 pericardial mesothelioma 10.2 KRT7 CEACAM5
79 gastric signet ring cell adenocarcinoma 10.2 KRT7 CDX2
80 malignant syringoma 10.2 KRT7 CEACAM5
81 rectum neuroendocrine neoplasm 10.2 KRT7 CDX2
82 syringoma 10.2 KRT7 CEACAM5
83 squamous cell bile duct carcinoma 10.2 KRT7 CEACAM5
84 adenoid squamous cell carcinoma 10.2 KRT7 CEACAM5
85 breast hemangioma 10.2 KRT7 CDX2
86 ossifying fibroma 10.2 SATB2 GNAS
87 pericardium cancer 10.2 KRT7 CEACAM5
88 cystitis cystica 10.2 KRT7 CDX2
89 cholangiolocellular carcinoma 10.2 KRT7 CEACAM5
90 squamous papillomatosis 10.2 KRT7 CEACAM5
91 external ear carcinoma 10.2 KRT7 CEACAM5
92 ovarian germ cell teratoma 10.2 KRT7 CEACAM5
93 bile duct cystadenoma 10.2 KRT7 CEACAM5
94 hidrocystoma 10.2 KRT7 CEACAM5
95 sublingual gland cancer 10.2 KRT7 CDX2
96 liver sarcoma 10.2 KRT7 CEACAM5
97 breast mucinous carcinoma 10.2 KRT7 CDX2
98 ovarian seromucinous carcinoma 10.2 KRT7 CDX2
99 secretory meningioma 10.2 KRT7 CEACAM5
100 lymphangitis 10.2 KRT7 CEACAM5
101 endometrial mucinous adenocarcinoma 10.2 KRAS GNAS
102 pulmonary artery leiomyosarcoma 10.2 KRT7 CEACAM5
103 urethral benign neoplasm 10.2 KRT7 CEACAM5
104 eccrine acrospiroma 10.2 KRT7 CEACAM5
105 eccrine sweat gland cancer 10.2 KRT7 CEACAM5
106 eccrine sweat gland neoplasm 10.2 KRT7 CEACAM5
107 glandular cystitis 10.2 KRT7 CDX2
108 signet ring basal cell carcinoma 10.2 KRAS CEACAM5
109 bladder clear cell adenocarcinoma 10.2 KRT7 CDX2
110 immature teratoma of ovary 10.2 KRAS CEACAM5
111 retinal melanoma 10.2 KRT7 CEACAM5
112 bartholin's gland carcinoma 10.2 KRT7 CDX2
113 vaginal glandular tumor 10.2 CHGA CEACAM5
114 apocrine sweat gland neoplasm 10.2 KRT7 CEACAM5
115 medullary colon carcinoma 10.2 KRT7 CDX2
116 thymus small cell carcinoma 10.2 CHGA CEACAM5
117 gastric small cell carcinoma 10.2 CHGA CEACAM5
118 pancreas lymphoma 10.2 CHGA CEACAM5
119 vulvar eccrine porocarcinoma 10.2 CHGA CEACAM5
120 cystic basal cell carcinoma 10.2 KRT7 CDX2
121 papillary thymic adenocarcinoma 10.2 CHGA CEACAM5
122 adult teratoma 10.2 CHGA CEACAM5
123 benign peritoneal mesothelioma 10.1 KRT7 CEACAM5
124 pancreatic serous cystadenoma 10.1 CHGA CEACAM5
125 peritoneal mesothelioma 10.1 KRT7 CEACAM5
126 adenofibroma 10.1 KRT7 KRAS
127 epididymis adenocarcinoma 10.1 KRT7 CDX2
128 epididymis cancer 10.1 KRT7 CDX2
129 bone benign neoplasm 10.1 SATB2 GNAS
130 anus basaloid carcinoma 10.1 KRT7 CDX2
131 ovarian germ cell cancer 10.1 KRT7 CEACAM5
132 mucocele of appendix 10.1
133 borst-jadassohn intraepidermal carcinoma 10.1 KRT7 CEACAM5
134 chronic cystitis 10.1 KRT7 CDX2
135 middle ear adenoma 10.1 KRT7 CHGA
136 pancreatic serous cystic neoplasm 10.1 KRT7 CHGA
137 vaginal discharge 10.1 KRT7 CEACAM5
138 auditory system benign neoplasm 10.1 KRT7 CHGA
139 sweat gland benign neoplasm 10.1 KRT7 CEACAM5
140 benign ileal neoplasm 10.1 CHGA CDX2
141 gallbladder small cell carcinoma 10.1 CHGA CEACAM5
142 breast papillary carcinoma 10.1 KRT7 CHGA
143 microcystic adenoma 10.1 CHGA CEACAM5
144 gastric hemangioma 10.1 CHGA CDX2
145 urinary bladder small cell neuroendocrine carcinoma 10.1 KRT7 CHGA
146 ureter small cell carcinoma 10.1 KRT7 CHGA
147 sensory organ benign neoplasm 10.1 KRT7 CHGA
148 peritoneum cancer 10.1 KRT7 CEACAM5
149 thyroid gland hurthle cell carcinoma 10.1 KRT7 CHGA
150 liver leiomyosarcoma 10.1 CHGA CEACAM5
151 fibroma 10.1 SATB2 KRT7 GNAS
152 small intestine benign neoplasm 10.1 CHGA CDX2
153 thymus large cell carcinoma 10.1 KRT7 CHGA
154 prostate neuroendocrine neoplasm 10.1 KRT7 CHGA
155 solid adenocarcinoma with mucin production 10.1 KRT7 CHGA
156 lung clear cell carcinoma 10.1 KRT7 CHGA
157 benign mesothelioma 10.1 KRT7 CEACAM5
158 meckel diverticulum 10.1 CHGA CDX2
159 basaloid squamous cell carcinoma 10.1 KRT7 CHGA
160 gallbladder signet ring cell adenocarcinoma 10.1 SATB2 KRT7 CDX2
161 nasal cavity cancer 10.1 KRT7 CDX2
162 polycystic liver disease 1 with or without kidney cysts 10.1 KRT7 CEACAM5
163 malignant olfactory nerve neoplasm 10.1 KRT7 CHGA
164 bladder adenocarcinoma 10.1 KRT7 CEACAM5 CDX2
165 pancreatic foamy gland adenocarcinoma 10.1 KRT7 CEACAM5 CDX2
166 ureter adenocarcinoma 10.1 KRT7 CEACAM5 CDX2
167 urinary bladder villous adenoma 10.0 KRT7 CEACAM5 CDX2
168 vulva adenocarcinoma 10.0 KRT7 CEACAM5 CDX2
169 aortic malignant tumor 10.0 KRT7 CEACAM5 CDX2
170 biliary papillomatosis 10.0 KRT7 CEACAM5 CDX2
171 mucinous ovarian cystadenoma 10.0 KRT7 CEACAM5 CDX2
172 mucinous adenofibroma 10.0 KRT7 CEACAM5 CDX2
173 sublingual gland adenoid cystic carcinoma 10.0 KRT7 CEACAM5 CDX2
174 anal paget's disease 10.0 KRT7 CEACAM5 CDX2
175 intussusception 10.0
176 ceroid lipofuscinosis, neuronal, 5 10.0
177 neuroendocrine tumor 10.0
178 linitis plastica 10.0 KRT7 CEACAM5 CDX2
179 nasal cavity olfactory neuroblastoma 10.0 KRT7 CEACAM5 CDX2
180 hepatoid adenocarcinoma 10.0 KRT7 CEACAM5 CDX2
181 gastric diffuse adenocarcinoma 10.0 KRT7 CEACAM5 CDX2
182 esophageal adenosquamous carcinoma 10.0 KRT7 CEACAM5 CDX2
183 paget disease, extramammary 10.0 KRT7 CEACAM5 CDX2
184 lung giant cell carcinoma 10.0 KRT7 KRAS
185 mature teratoma 10.0 KRT7 CEACAM5 CDX2
186 tumor predisposition syndrome 2 10.0
187 mucinous adenocarcinoma of the appendix 10.0
188 struma ovarii 10.0 KRT7 KRAS
189 pancreatic cystadenocarcinoma 10.0 SATB2 KRAS CEACAM5
190 thoracic benign neoplasm 10.0 KRT7 CEACAM5
191 ethmoid sinus adenocarcinoma 10.0 HRAS CDX2
192 ethmoid sinus cancer 10.0 HRAS CDX2
193 sweat gland disease 10.0 KRT7 CEACAM5
194 bladder cancer 10.0
195 oculodentodigital dysplasia 10.0
196 factor vii deficiency 10.0
197 mycobacterium tuberculosis 1 10.0
198 miliary tuberculosis 10.0
199 ovarian large-cell neuroendocrine carcinoma 10.0 KRT7 CHGA CEACAM5
200 mediastinal cancer 10.0 KRT7 CHGA CEACAM5
201 intrahepatic bile duct adenoma 10.0 KRT7 CHGA CEACAM5
202 breast myoepithelial neoplasm 10.0 KRT7 HRAS
203 breast adenomyoepithelioma 10.0 KRT7 HRAS
204 endodermal sinus tumor 10.0 KRT7 CHGA CEACAM5
205 small cell carcinoma 10.0 KRT7 CHGA CEACAM5
206 papillary carcinoma 10.0 KRT7 GNAS CHGA
207 acinar cell carcinoma 10.0 KRT7 CHGA
208 vaginal adenoma 10.0 KRT7 CHGA CDX2
209 squamous cell papilloma 10.0 KRT7 HRAS
210 small cell cancer of the lung 9.9 KRT7 CHGA CEACAM5
211 bladder transitional cell papilloma 9.9 KRT7 HRAS
212 mammary paget's disease 9.9 KRT7 CEACAM5
213 trachea carcinoma in situ 9.9 KRAS HRAS
214 urinary tract papillary transitional cell benign neoplasm 9.9 KRT7 HRAS
215 bladder papillary transitional cell neoplasm 9.9 KRT7 HRAS
216 duodenal benign neoplasm 9.9 HRAS CHGA
217 renal pelvis transitional cell carcinoma 9.9 KRT7 HRAS
218 adenosquamous lung carcinoma 9.9 KRAS HRAS
219 acneiform dermatitis 9.9 KRAS HRAS
220 ovarian mucinous adenocarcinoma 9.9 SATB2 KRT7 CEACAM5 CDX2
221 thyroid carcinoma, familial medullary 9.9 KRAS CHGA CEACAM5
222 noonan syndrome-like disorder with loose anagen hair 1 9.9 KRAS HRAS
223 vaginal cancer 9.9 KRT7 HRAS
224 liver angiosarcoma 9.9 KRAS HRAS
225 carcinoid tumors, intestinal 9.9
226 volvulus of midgut 9.9
227 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.9
228 gallbladder disease 1 9.9
229 diverticulitis of colon 9.9
230 cholecystitis 9.9
231 diverticulitis 9.9
232 epithelial tumor of the appendix 9.9
233 neuroendocrine neoplasm of appendix 9.9
234 mucinous lung adenocarcinoma 9.9 KRAS HRAS
235 large cell carcinoma with rhabdoid phenotype 9.9 KRAS HRAS
236 inflammatory bowel disease 1 9.9
237 colitis 9.9
238 leiomyoma 9.9
239 cholestasis 9.9
240 neurilemmoma 9.9
241 ileus 9.9
242 ulcerative colitis 9.9
243 crohn's disease 9.9
244 undetermined colitis 9.9
245 cecum adenocarcinoma 9.9 KRAS HRAS
246 bronchus cancer 9.9 KRT7 CEACAM5
247 oculoectodermal syndrome 9.9 KRAS HRAS
248 thyroid tumor 9.9 KRAS HRAS
249 ovarian carcinosarcoma 9.9 KRAS HRAS
250 cutaneous ganglioneuroma 9.9 HRAS CHGA
251 paronychia 9.9 KRAS HRAS
252 hemangioma 9.9 KRT7 KRAS CHGA
253 endometrioid ovary carcinoma 9.8 KRAS HRAS
254 infiltrating angiolipoma 9.8 KRAS HRAS
255 pulmonic stenosis 9.8 KRAS HRAS
256 dermatopathia pigmentosa reticularis 9.8 KRAS HRAS
257 peutz-jeghers syndrome 9.8
258 contractures, pterygia, and spondylocarpotarsal fusion syndrome 1a 9.8
259 tuberous sclerosis 2 9.8
260 leptin deficiency or dysfunction 9.8
261 leptin receptor deficiency 9.8
262 hydronephrosis 9.8
263 toxic encephalopathy 9.8
264 49, xxxxy syndrome 9.8
265 ovarian epithelial cancer 9.8
266 lung non-squamous non-small cell carcinoma 9.8 KRAS HRAS
267 syringocystadenoma papilliferum 9.8 KRT7 HRAS CEACAM5
268 gastroesophageal adenocarcinoma 9.8 KRAS HRAS
269 vulvar disease 9.8 KRT7 HRAS CEACAM5
270 noonan syndrome and noonan-related syndrome 9.8 KRAS HRAS
271 endocervical carcinoma 9.8 KRT7 HRAS CEACAM5
272 colorectal cancer 9.8
273 coloboma of optic nerve 9.8
274 lynch syndrome 1 9.8
275 ovarian cancer 9.8
276 ovarian cancer 1 9.8
277 diffuse gastric cancer 9.8
278 neuroendocrine carcinoma 9.8
279 endocervical adenocarcinoma 9.8 KRT7 HRAS CEACAM5
280 vulva cancer 9.8 KRT7 HRAS CEACAM5
281 nasal cavity adenocarcinoma 9.8 KRT7 HRAS CDX2
282 noonan syndrome 3 9.8 KRAS HRAS
283 differentiated thyroid carcinoma 9.8 KRAS HRAS
284 cholangiocarcinoma 9.8 KRT7 KRAS CEACAM5 CDX2
285 vaginal tubulovillous adenoma 9.8 KRT7 CHGA CEACAM5 CDX2
286 pseudo-turner syndrome 9.8 KRAS HRAS
287 rectosigmoid junction neoplasm 9.8 KRT7 KRAS CEACAM5 CDX2
288 female urethral cancer 9.8 KRT7 CHGA CEACAM5 CDX2
289 jejunal cancer 9.8 KRT7 CHGA CEACAM5 CDX2
290 vaginal benign neoplasm 9.8 KRT7 CHGA CEACAM5 CDX2
291 cystic teratoma 9.8 KRT7 CHGA CEACAM5 CDX2
292 cecal disease 9.8 KRT7 CHGA CEACAM5 CDX2
293 benign teratoma 9.8 KRT7 CHGA CEACAM5 CDX2
294 cervical adenocarcinoma 9.8 KRT7 KRAS CEACAM5 CDX2
295 common bile duct neoplasm 9.8 KRAS HRAS GNAS
296 ras-associated autoimmune leukoproliferative disorder 9.8 KRAS HRAS
297 schimmelpenning-feuerstein-mims syndrome 9.8 KRAS HRAS GNAS
298 hepatic flexure cancer 9.8 KRAS HRAS CEACAM5
299 nevus, epidermal 9.8 KRAS HRAS GNAS
300 pancreatic mucinous cystadenoma 9.8 KRAS HRAS CEACAM5
301 transverse colon cancer 9.8 KRAS HRAS CEACAM5
302 pancreatic signet ring cell adenocarcinoma 9.8 KRAS HRAS CEACAM5
303 rectosigmoid cancer 9.8 KRAS HRAS CEACAM5
304 lung adenoma 9.8 KRAS HRAS
305 colorectal adenoma 9.7 KRAS HRAS CEACAM5
306 colon adenoma 9.7 KRAS HRAS CDX2
307 skin melanoma 9.7 KRAS HRAS GNAS
308 mismatch repair cancer syndrome 9.7 KRAS HRAS
309 vaginal carcinosarcoma 9.7 KRT7 KRAS HRAS
310 carcinosarcoma 9.7 KRT7 KRAS HRAS
311 adenoid cystic carcinoma 9.7 KRT7 KRAS HRAS
312 serous cystadenocarcinoma 9.7 KRT7 KRAS HRAS
313 cystadenofibroma 9.7 KRT7 KRAS HRAS
314 endosalpingiosis 9.7 KRT7 KRAS HRAS
315 lung carcinoma in situ 9.7 KRT7 KRAS HRAS
316 pulmonary adenocarcinoma in situ 9.7 KRT7 KRAS HRAS
317 lung sarcomatoid carcinoma 9.7 KRT7 KRAS HRAS
318 female reproductive endometrioid cancer 9.7 KRT7 KRAS HRAS
319 pre-malignant neoplasm 9.7 KRT7 KRAS HRAS
320 renal cell carcinoma, papillary, 1 9.7 KRT7 KRAS HRAS
321 ampulla of vater benign neoplasm 9.7 KRAS HRAS CHGA
322 pancreatic acinar cell adenocarcinoma 9.7 KRAS HRAS CHGA
323 keratinizing squamous cell carcinoma 9.6 KRT7 HRAS CEACAM5 CDX2
324 paraganglioma 9.6 KRT7 HRAS CHGA
325 lung squamous cell carcinoma 9.6 KRAS HRAS CEACAM5
326 ovarian serous cystadenocarcinoma 9.6 KRAS HRAS GNAS CEACAM5
327 descending colon cancer 9.6 KRAS HRAS CEACAM5 CDX2
328 cecum carcinoma 9.6 KRAS HRAS CEACAM5 CDX2
329 intrahepatic cholangiocarcinoma 9.6 KRT7 KRAS HRAS CEACAM5
330 pleomorphic carcinoma 9.6 KRT7 KRAS HRAS CEACAM5
331 papillary adenoma 9.6 KRT7 KRAS HRAS CEACAM5
332 squamous cell carcinoma 9.6 KRT7 KRAS HRAS CEACAM5
333 bile duct cysts 9.6 KRT7 KRAS HRAS CEACAM5
334 ovarian benign neoplasm 9.6 KRT7 KRAS HRAS CEACAM5
335 klatskin's tumor 9.6 KRT7 KRAS HRAS CEACAM5
336 papillary serous adenocarcinoma 9.6 KRT7 KRAS HRAS CEACAM5
337 reproductive organ benign neoplasm 9.6 KRT7 KRAS HRAS CEACAM5
338 bladder urachal carcinoma 9.5 KRT7 KRAS HRAS CDX2
339 urachus cancer 9.5 KRT7 KRAS HRAS CDX2
340 bile duct adenocarcinoma 9.5 KRT7 KRAS HRAS CEACAM5
341 malignant ovarian surface epithelial-stromal neoplasm 9.5 KRT7 KRAS HRAS CEACAM5
342 cholangitis, primary sclerosing 9.5 KRT7 KRAS HRAS CEACAM5
343 gallbladder disease 9.5 KRT7 KRAS HRAS CEACAM5
344 cervix carcinoma 9.5 KRT7 KRAS HRAS CEACAM5
345 periampullary adenocarcinoma 9.5 KRT7 KRAS HRAS CDX2
346 bile duct disease 9.5 KRT7 KRAS HRAS CEACAM5
347 small intestine adenocarcinoma 9.5 KRT7 KRAS HRAS CDX2
348 biliary tract disease 9.5 KRT7 KRAS HRAS CEACAM5
349 breast adenocarcinoma 9.5 KRT7 KRAS HRAS CEACAM5
350 ampulla of vater adenocarcinoma 9.5 KRT7 KRAS HRAS CDX2
351 wilms tumor 1 9.5 KRT7 KRAS HRAS CEACAM5
352 teratoma 9.5 KRT7 KRAS CHGA CEACAM5 CDX2
353 pancreatoblastoma 9.5 KRAS HRAS CHGA CEACAM5
354 pancreatic adenocarcinoma 9.5 KRAS HRAS GNAS
355 adrenal cortical carcinoma 9.5 KRAS HRAS GNAS CHGA
356 gastrointestinal stromal tumor 9.5 KRAS HRAS CHGA CEACAM5
357 familial adenomatous polyposis 2 9.5 KRAS HRAS
358 blastoma 9.5 KRT7 KRAS HRAS CHGA
359 large cell neuroendocrine carcinoma 9.5 KRT7 KRAS HRAS CHGA
360 lung large cell carcinoma 9.5 KRT7 KRAS HRAS CHGA
361 respiratory system benign neoplasm 9.5 KRT7 KRAS HRAS CHGA
362 pancreatic ductal carcinoma 9.5 KRT7 KRAS HRAS CHGA
363 lung benign neoplasm 9.5 KRT7 KRAS HRAS CHGA
364 mucinous intrahepatic cholangiocarcinoma 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
365 sigmoid neoplasm 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
366 ascending colon cancer 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
367 biliary tract benign neoplasm 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
368 duodenum adenocarcinoma 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
369 adenocarcinoma in situ 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
370 clear cell basal cell carcinoma 9.4 KRT7 HRAS CHGA CEACAM5 CDX2
371 gallbladder adenocarcinoma 9.4 KRT7 HRAS CHGA CEACAM5 CDX2
372 anus disease 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
373 rectal disease 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
374 bronchiolo-alveolar adenocarcinoma 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
375 papillary adenocarcinoma 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
376 ampulla of vater cancer 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
377 small intestine cancer 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
378 rectum adenocarcinoma 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
379 lymphangioma 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
380 bile duct cancer 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
381 gallbladder cancer 9.4 KRT7 KRAS HRAS CEACAM5 CDX2
382 mixed cell type cancer 9.3 KRT7 KRAS HRAS CHGA CEACAM5
383 adenosquamous carcinoma 9.3 KRT7 KRAS HRAS CHGA CEACAM5
384 cardiovascular organ benign neoplasm 9.3 KRT7 KRAS HRAS CHGA CEACAM5
385 large cell carcinoma 9.3 KRT7 KRAS HRAS CHGA CEACAM5
386 thyroid gland cancer 9.3 KRT7 KRAS HRAS CHGA CEACAM5
387 rhabdomyosarcoma 9.3 KRT7 KRAS HRAS CHGA CEACAM5
388 endometrial cancer 9.2 KRT7 KRAS HRAS CEACAM5 CDX2
389 ovarian mucinous neoplasm 9.2 SATB2 KRT7 KRAS HRAS CEACAM5 CDX2
390 lung cancer susceptibility 3 9.2 KRT7 KRAS HRAS GNAS CEACAM5 CDX2
391 gastric adenocarcinoma 9.1 KRAS HRAS GNAS CHGA CEACAM5 CDX2
392 duodenum cancer 9.1 KRT7 KRAS HRAS CHGA CEACAM5 CDX2
393 duodenum disease 9.1 KRT7 KRAS HRAS CHGA CEACAM5 CDX2
394 gastrointestinal system benign neoplasm 9.1 KRT7 KRAS HRAS CHGA CEACAM5 CDX2
395 pancreatic cancer 8.9 KRT7 KRAS HRAS CHGA CEACAM5 CDX2
396 appendix disease 8.7 SATB2 PEX19 KRT7 KRAS HRAS GNAS

Graphical network of the top 20 diseases related to Appendiceal Neoplasm:



Diseases related to Appendiceal Neoplasm

Symptoms & Phenotypes for Appendiceal Neoplasm

GenomeRNAi Phenotypes related to Appendiceal Neoplasm according to GeneCards Suite gene sharing:

25 (showing 1, show less)
# Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Reduced mammosphere formation GR00396-S 9.02 CHGA GNAS HRAS KRAS KRT7

MGI Mouse Phenotypes related to Appendiceal Neoplasm:

45 (showing 3, show less)
# Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 9.55 CDX2 CEACAM5 GNAS HRAS KRAS
2 endocrine/exocrine gland MP:0005379 9.5 CDX2 CEACAM5 CHGA GNAS HRAS KRAS
3 digestive/alimentary MP:0005381 9.1 CDX2 CEACAM5 GNAS HRAS KRAS SATB2

Drugs & Therapeutics for Appendiceal Neoplasm

Drugs for Appendiceal Neoplasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 66, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Durvalumab Approved, Investigational Phase 1, Phase 2 1428935-60-7
2
Cyclophosphamide Approved, Investigational Phase 1, Phase 2 50-18-0, 6055-19-2 2907
3
Thalidomide Approved, Investigational, Withdrawn Phase 2 50-35-1 5426
4
Mitomycin Approved Phase 2 50-07-7 5746
5
Paclitaxel Approved, Vet_approved Phase 2 33069-62-4 36314
6
Levoleucovorin Approved, Experimental, Investigational Phase 2 68538-85-2, 58-05-9, 73951-54-9 149436 6006
7
Melphalan Approved Phase 2 148-82-3 4053 460612
8
Cetuximab Approved Phase 1, Phase 2 205923-56-4
9
Floxuridine Approved Phase 2 50-91-9 5790
10
Capecitabine Approved, Investigational Phase 2 154361-50-9 60953
11
Amoxicillin Approved, Vet_approved Phase 2 26787-78-0 33613
12
Carbamide peroxide Approved Phase 2 124-43-6
13
Dexlansoprazole Approved, Investigational Phase 2 138530-94-6 9578005
14
Lansoprazole Approved, Investigational Phase 2 103577-45-3 3883
15
Clarithromycin Approved Phase 2 81103-11-9 84029
16
Oxaliplatin Approved, Investigational Phase 2 61825-94-3 43805 11947679 6857599
17
Nintedanib Approved Phase 2 656247-17-5 135423438 9809715
18
Irinotecan Approved, Investigational Phase 2 97682-44-5, 100286-90-6 60838
19
Nivolumab Approved Phase 2 946414-94-4
20
Ipilimumab Approved Phase 2 477202-00-9
21
Folic acid Approved, Nutraceutical, Vet_approved Phase 2 59-30-3 6037
22
Exatecan Investigational Phase 1, Phase 2 171335-80-1 18546929 151115
23 Angiogenesis Inhibitors Phase 2
24 Albumin-Bound Paclitaxel Phase 2
25 Antimitotic Agents Phase 2
26 Tubulin Modulators Phase 2
27 Alkylating Agents Phase 2
28 Antineoplastic Agents, Alkylating Phase 2
29 Immunosuppressive Agents Phase 2
30 Immunologic Factors Phase 2
31 Vitamins Phase 2
32 Folate Phase 2
33 Vitamin B9 Phase 2
34 Trace Elements Phase 2
35 Vitamin B Complex Phase 2
36 Antimetabolites Phase 2
37 Antidotes Phase 2
38 Micronutrients Phase 2
39 Protective Agents Phase 2
40 Cola Phase 2
41 Antibiotics, Antitubercular Phase 2
42 Anti-Ulcer Agents Phase 2
43 Anti-Bacterial Agents Phase 2
44 Anti-Infective Agents Phase 2
45 Antacids Phase 2
46 Proton Pump Inhibitors Phase 2
47 Cytochrome P-450 Enzyme Inhibitors Phase 2
48 Gastrointestinal Agents Phase 2
49 Cytochrome P-450 CYP3A Inhibitors Phase 2
50 Protein Kinase Inhibitors Phase 2
51 Antineoplastic Agents, Immunological Phase 2
52 topoisomerase I inhibitors Phase 2
53 Immune Checkpoint Inhibitors Phase 2
54
Cisplatin Approved Phase 1 15663-27-1 2767 5702198 441203
55
Daunorubicin Approved Phase 1 20830-81-3 30323
56
Doxorubicin Approved, Investigational Phase 1 23214-92-8 31703
57
Fluorouracil Approved Phase 1 51-21-8 3385
58 Liposomal doxorubicin Phase 1
59 Pharmaceutical Solutions Phase 1
60
Sodium thiosulfate Phase 1
61 Antitubercular Agents Phase 1
62 Antioxidants Phase 1
63 Chelating Agents Phase 1
64 Tin Fluorides Phase 1
65
Gemcitabine Approved 95058-81-4, 122111-03-9 60750
66
Formaldehyde Approved, Vet_approved 50-00-0 712

Interventional clinical trials:

(showing 37, show less)
# Name Status NCT ID Phase Drugs
1 Repetitive Electrostatic Pressurised Intraperitoneal Aerosol Chemotherapy With Oxaliplatin (ePIPAC-OX) as a Palliative Monotherapy for Isolated Unresectable Colorectal Peritoneal Metastases: Protocol of a Multicentre, Open-label, Single-arm, Phase II Study (CRC-PIPAC) Completed NCT03246321 Phase 2
2 Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C Completed NCT02040142 Phase 2 Mitomycin C
3 A Phase 1/2 Dose Escalation Study With Expansion Cohorts to Investigate the Safety, Biologic and Anti-tumor Activity of ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Completed NCT02963831 Phase 1, Phase 2 Durvalumab
4 Phase II Trial of Adjuvant Thalidomide Following Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis or Adenomucinosis From Colorectal/Appendiceal Cancer Completed NCT00310076 Phase 2 thalidomide
5 Phase II Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Ovarian, or Other Gynecologic Primary Cancer Recruiting NCT05185947 Phase 2 Paclitaxel;Nilotinib
6 Phase II Single-Blind Randomized Trial Comparing Morbidity of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (CRS-HIPEC) Using Mitomycin-C Versus Melphalan for Colorectal Peritoneal Carcinomatosis Recruiting NCT03073694 Phase 2 Mitomycin c;Melphalan
7 A Phase 1/2 Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors Recruiting NCT04902872 Phase 1, Phase 2 CBX-12
8 Randomized Controlled Trial of Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes Recruiting NCT04907643 Phase 2
9 A Phase Ib/II Trial of JAB-21822 in Combination With Cetuximab in Patients With Advanced Colorectal Cancer, Small Intestine Cancer and Appendiceal Cancer With KRAS G12C Mutation Recruiting NCT05194995 Phase 1, Phase 2 JAB-21822;Cetuximab
10 ICARuS (Intraperitoneal Chemotherapy After cytoReductive Surgery): A Multi-center, Randomized Phase II Trial of Early Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis Recruiting NCT01815359 Phase 2 HIPEC with Mitomycin-C;EPIC with FUDR and Leucovorin
11 Surufatinib and Sintilimab in Combination With Capecitabine in Patients With Previously Treated Metastatic Adenocarcinoma of Small Intestine or Appendix Carcinoma : a Single-arm, a Single-center , Phase 2 Trial Recruiting NCT05472948 Phase 2 Surufatinib
12 Clinical Trial to Define the Effect of Perioperative H. Pylori Eradication With Antibiotic Treatment on Long Term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin Undergoing Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy Active, not recruiting NCT02387203 Phase 2 PrevPac (Prevacid, Amoxicillin, Clarithromycin)
13 LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma Terminated NCT03287947 Phase 2 nintedanib
14 A Phase II Study of Nivolumab and Ipilimumab in Mucinous Colorectal and Appendiceal Tumors Terminated NCT03693846 Phase 2 Nivolumab;Ipilimumab
15 Treatment of a Cancerous Disease of the Peritoneum With Complete Cytoreductive Surgery With Intraperitoneal Chemohyperthermia Using Oxaliplatin Plus Irinotecan Terminated NCT00180960 Phase 2 Oxaliplatin and irinotecan
16 Phase I Trial of Intraperitoneal Oxaliplatin in Combination With Intravenous FOLFIRI (5-fluorouracil, Leucovorin and Irinotecan) for Peritoneal Carcinomatosis From Colorectal and Appendiceal Cancer Completed NCT02833753 Phase 1 Oxaliplatin
17 Safety and Efficacy of Pressurized Intraperitoneal Aerosolized Chemotherapy (PIPAC) in Ovarian, Uterine, Appendiceal, Colorectal, and Gastric Cancer Patients With Peritoneal Carcinomatosis (PC) Recruiting NCT04329494 Phase 1 Cisplatin;Doxorubicin;Fluorouracil;Irinotecan;Leucovorin;Mitomycin;Oxaliplatin
18 Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies Recruiting NCT04847063 Phase 1 Mitomycin C;Cisplatin;Doxorubicin;Oxaliplatin;5-Fluorouracil;Sodium Thiosulfate
19 Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal Cancer: a Phase I Study Not yet recruiting NCT05277766 Phase 1 PIPAC with Nal-IRI
20 Phase I Trial of Intraperitoneal Oxaliplatin in Combination With Intravenous mFOLFIRI for Peritoneal Carcinomatosis From Colorectal and Appendiceal Cancer Terminated NCT04158349 Phase 1 Oxaliplatin;mFOLFIRI
21 Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy; the FANCY Study. Unknown status NCT03510923
22 Multicenter, International Online Documentation of Indications and Results of Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC Und PITAC) for Treating Malignant Peritoneal and Pleural Diseases Unknown status NCT03210298
23 A Survey of the Knowledge, Attitudes, and Practice of Surgeons Toward Nutrition Support in HIPEC Patients Completed NCT02374411
24 Distant Metastases and Long-Term Survival After Complete Resection of Neuroendocrine Tumors of the Appendix: An International Multicenter Study Completed NCT03852693
25 Trial of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Primary Peritoneal Cancers and Secondary Peritoneal Cancers From Stomach, Colorectal, Appendiceal, and/or Gynecological Origins Completed NCT03604653 Mitomycin c;CDDP 50;CDDP 75;Doxorubicin
26 GI 1549: PROGRAMS TO SUPPORT YOU DURING CHEMOTHERAPY (PRO-YOU) A Randomized Controlled Pilot Study of Yoga Compared to an Attention Control in Patients Receiving Chemotherapy Completed NCT02489422
27 Surgical Outcome and Predictors of Overall Survival of Stage I-III Appendiceal Adenocarcinoma; a National Cancer Database Analysis Completed NCT05452382
28 A Cohort Study of the Gastrointestinal Microbiome in Appendiceal Cancer With Peritoneal Spread Recruiting NCT02599116
29 A Phase II Trial to Analyze Clinical and Pharmacological Properties for Severe Neutropenia After Cytoreductive Surgery Followed by Hyperthermic Intraperitoneal Chemotherapy Using Mitomycin-C Recruiting NCT05513183
30 Diagnostic Value of Diffusion-weighted Magnetic Resonance Imaging for Detection of Peritoneal Recurrence in Patients With High-risk Colorectal and Appendiceal Neoplasms : a Pilot Study Recruiting NCT05623787
31 5-hydroxymethylation Signatures in Plasma Circulating Cell-free DNA as Markers for Tumor Burden and Recurrence in Appendiceal and Colorectal Peritoneal Metastasis Recruiting NCT04157322
32 The Registry of Oncology Outcomes Associated With Testing and Treatment (ROOT) Recruiting NCT04028479 Systemic Treatment (T)
33 The PANO Trial: Perioperative Exercise and Nutrition Optimisation Prehabilitation in Cancer Patients With Peritoneal Malignancy Recruiting NCT05305820
34 A Pragmatic, Single-Arm Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy Recruiting NCT04526886
35 The Prevalence of Appendiceal Tumours in Patients Presenting With a Periappendicular Abscess - A Nationwide Prospective Cohort Study Not yet recruiting NCT04634448
36 Justification of Incidental Appendectomy With Respect to Pathohistological Findings Not yet recruiting NCT05202600
37 Characterisation of Appendiceal Cancer by Genomic and Transcriptomic Analysis and Correlation With Clinical Outcomes Not yet recruiting NCT05364788

Search NIH Clinical Center for Appendiceal Neoplasm

Genetic Tests for Appendiceal Neoplasm

Anatomical Context for Appendiceal Neoplasm

Organs/tissues related to Appendiceal Neoplasm:

MalaCards : Appendix, Small Intestine, Colon, Lymph Node, Ovary, T Cells, Liver

Publications for Appendiceal Neoplasm

Articles related to Appendiceal Neoplasm:

(showing 593, show less)
# Title Authors PMID Year
1
Incomplete cytoreduction with peritoneal metastases from appendiceal mucinous neoplasms. 62
36102369 2022
2
Do Lymph Node Metastases Matter in Appendiceal Cancer with Peritoneal Carcinomatosis? A US HIPEC Collaborative Study. 62
36258061 2022
3
Overall Survival after Systemic Chemotherapy in Patients with High-Grade Appendiceal Cancer Undergoing Cytoreductive Surgery/Hyperthermic Intraperitoneal Chemotherapy (CRS/HIPEC). 62
36344797 2022
4
The appendix "mucocoele" misnomer: radiological terminology of "likely appendix mucinous neoplasm" better reflects pathology findings. 62
36411089 2022
5
Beware the distended appendix: technical adaptations to an appendicectomy when an appendiceal neoplasm is suspected. 62
36454069 2022
6
An Ex Vivo Organotypic Culture Platform for Functional Interrogation of Human Appendiceal Cancer Reveals a Prominent and Heterogenous Immunological Landscape. 62
36067351 2022
7
Peristomal Necrosis Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: A Case Report. 62
36417381 2022
8
Validation of a Nomogram to Predict Recurrence in Patients with Mucinous Neoplasms of the Appendix with Peritoneal Dissemination After Cytoreductive Surgery and HIPEC. 62
35876926 2022
9
Retroperitoneal mass, a rare manifestation of mucinous adenocarcinoma of appendix: A case report. 62
36415704 2022
10
Inherited Cancer Susceptibility Gene Sequence Variations Among Patients With Appendix Cancer. 62
36368039 2022
11
Appendiceal Goblet Cell Adenocarcinoma: A Historically Informed Reading of 6 Cases. 62
35142802 2022
12
ASO Author Reflections: CRS/HIPEC Cannot be Done-Now what? Systemic Chemotherapy in Mucinous Appendiceal Cancer. 62
35644859 2022
13
Acute lower gastrointestinal bleeding due to low-grade mucinous neoplasm of appendix. 62
33274692 2022
14
ASO Visual Abstract: Socioeconomic Barriers to CRS HIPEC for Appendiceal Cancer within a Regional Academic Hospital System. 62
35798897 2022
15
Clinicopathological spectrums and prognosis of primary appendiceal adenocarcinoma, goblet cell adenocarcinoma, and low-grade appendiceal mucinous neoplasms. 62
36454563 2022
16
Socioeconomic Barriers to CRS HIPEC for Appendiceal Cancer within a Regional Academic Hospital System. 62
35639293 2022
17
Systemic Chemotherapy for High-Grade Mucinous Appendiceal Cancer with Peritoneal Spread After Unsuccessful CRS/HIPEC. 62
35641710 2022
18
Diverticulitis and Diverticulosis of the Appendix: A Case Series. 62
36447679 2022
19
Amyand's hernia: which oncologic risk can be hidden in the sac? 62
36134747 2022
20
Incidental Appendiceal Tumors During Appendectomy: A Nineteen-Year Retrospective Review at a Municipal Hospital. 62
36074007 2022
21
Adjuvant chemotherapy for high-grade appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. 62
36253240 2022
22
Primary Appendiceal Adenocarcinoma Masquerading as Acute Appendicitis: A Case Report. 62
36225475 2022
23
Treatment Patterns of Real-World Patients with TRK Fusion Cancer Treated by US Community Oncologists. 62
36089643 2022
24
Is Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy Still Indicated in Patients With Extraperitoneal Disease? 62
35525209 2022
25
Second-look Surgery for Appendiceal High Grade and Colorectal Cancers Following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC). 62
36099142 2022
26
Initial Experience of Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Baltic Country Center. 62
36233421 2022
27
An unusual case of appendicitis due to appendiceal neuroendocrine tumor in a patient: A case report. 62
35837025 2022
28
Clinicopathological features of appendiceal goblet cell adenocarcinoma in Japan: a multicenter retrospective study. 62
35913635 2022
29
Signet-ring cell carcinoma of the appendix with ganglioneuromatosis: a case report. 62
35927360 2022
30
Revisiting the necessity for routine appendectomies in mucinous neoplasms of the ovary: An evaluation of 460 mucinous ovarian tumors. 62
35439697 2022
31
Accidental discovery of appendiceal carcinoma during gynecological surgery: A case report. 62
36158468 2022
32
Short and long-term outcomes of cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for colorectal and appendiceal cancer peritoneal metastasis: Propensity score-matched comparison between laparoscopy vs. open approaches. 62
35430126 2022
33
Cerebral Metastases in Appendiceal Cancer: Comprehensive Review and Report of Rare Medullary Carcinoma Histology. 62
35929119 2022
34
Mucinous appendiceal neoplasms and pseudomyxoma peritonei: Morphological and clinical findings, differential diagnosis, and prognosis. 62
35900483 2022
35
Lymph node positive pseudomyxoma peritonei. 62
35941031 2022
36
Early postoperative intraperitoneal chemotherapy (EPIC) following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in 632 patients with pseudomyxoma peritonei of appendiceal origin: A single institution experience. 62
35168851 2022
37
Bone metaplasia of the appendix presented with clinical and computed tomography signs of acute appendicitis managed with laparoscopic appendectomy. 62
35915527 2022
38
Prognostic Impact of Pathology, Cytoreduction, and Tumor Markers in Pseudomyxoma Peritonei. 62
35123285 2022
39
Incidental Finding of Appendiceal Mucinous Neoplasm After Trauma: A Case Report. 62
35836463 2022
40
ASO Author Reflections: If at First You Don't Succeed, Try, Try Again: Iterative CRS/HIPEC for Recurrent Mucinous Appendix Cancer. 62
35015184 2022
41
Appendiceal Cancer in the National Cancer Database: Increasing Frequency, Decreasing Age, and Shifting Histology. 62
35703801 2022
42
Survival and prognostic factors for postoperative primary appendiceal cancer: a retrospective cohort study based on the Surveillance, Epidemiology, and End Results database. 62
35837159 2022
43
After thirty years of experience with early postoperative intraperitoneal 5-fluorouracil now saying goodbye. 62
35398760 2022
44
Iterative Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Mucinous Adenocarcinoma of the Appendix. 62
35133518 2022
45
Case series on high grade appendiceal cancer with peritoneal and liver carcinomatosis undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). 62
35398783 2022
46
A Canadian single-centre experience with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for abdominal malignancies. 62
35580884 2022
47
The association between appendicitis severity and patient age with appendiceal neoplasm histology-a population-based study. 62
35474547 2022
48
Incidental Findings of Appendiceal Diverticulitis Presenting as Acute Appendicitis. 62
34937429 2022
49
Re: Tuberculosis, still the great mimicker: a rare case of disseminated tuberculosis masquerading as appendiceal cancer with peritoneal carcinomatosis. 62
35434958 2022
50
A case report of appendiceal adenocarcinoma without gastrointestinal evidence mimicking primary ovarian cancer. 62
35387517 2022
51
Validating the PSOGI classification of peritoneal disease from non-carcinoid epithelial appendiceal neoplasms in the curative and palliative setting: an observational retrospective study. 62
35557579 2022
52
ASO Author Reflections: Neoadjuvant Chemotherapy for High-Grade Appendiceal Neoplasms Before Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy, Closer to Evidence-Based Practice? 62
35001235 2022
53
Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. 62
35022900 2022
54
Utility of hyperthermic intraperitoneal chemotherapy in cases of incomplete cytoreductive surgery. 62
34841542 2022
55
Neoplasms of the appendix: Single institution and ten-year experiences results. 62
35485573 2022
56
Appendiceal Diverticulitis Presenting as Acute Appendicitis and Diagnosed After Appendectomy. 62
35464547 2022
57
Establishing Novel Molecular Subtypes of Appendiceal Cancer. 62
34718915 2022
58
ASO Author Reflections: Establishing Novel Molecular Subtypes of Appendiceal Cancer. 62
34708274 2022
59
The incidence and prognostic importance of ovarian involvement in patients with peritoneal metastasis undergoing CRS-HIPEC. 62
34799231 2022
60
Controversies in appendiceal pathology: mucinous and goblet cell neoplasms. 62
34836648 2022
61
Progression of perforated cystadenoma of the appendix to pseudomyxoma peritonei over 18 years. A case report. 62
35032752 2022
62
Misdiagnosis of appendiceal neoplasms as ovarian tumors: Impact of prior gynecologic surgery on definitive cytoreduction and HIPEC. 62
34454813 2022
63
Locally advanced perforated appendiceal cancer: Case report and review. 62
35169467 2022
64
Incidence, Risk Factors, and Outcomes from Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Patients Undergoing Multiple Cytoreductive Surgeries with Hyperthermic Intraperitoneal Chemotherapy. 62
34455511 2022
65
Acute Perforated Appendicitis Associated with Appendiceal Diverticulitis in a Young Man: A Case Report with Literature Review. 62
35022381 2022
66
[Appendiceal cancer]. 62
35147005 2022
67
The role of chemotherapy in the treatment of advanced appendiceal cancers: summary of the literature and future directions. 62
35898968 2022
68
Establishment and validation of the survival prediction risk model for appendiceal cancer. 62
36388937 2022
69
Efficacy and safety in the use of intraperitoneal hyperthermia chemotherapy and peritoneal cytoreductive surgery for pseudomyxoma peritonei from appendiceal neoplasm: A systematic review. 62
35576869 2022
70
Outcomes and prognostic factors of cytoreductive surgery and perioperative intraperitoneal chemotherapy in high-volume peritoneal carcinomatosis. 62
35993246 2022
71
ASO Author Reflections: Evaluating Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy. 62
34467501 2022
72
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in appendix cancer A single-center experience. 62
36254768 2022
73
A rare triad of appendiceal diverticula, appendiceal carcinoid, and colonic diverticula. 62
35783670 2022
74
[Clinicopathological analysis and surgical strategy of primary appendiceal neoplasms]. 62
34923789 2021
75
Tuberculosis, still the great mimicker: a rare case of disseminated tuberculosis masquerading as appendiceal cancer with peritoneal carcinomatosis. 62
33788360 2021
76
Laparoscopic appendectomy for appendiceal intussusception assisted by colonoscopy: A case report. 62
34801781 2021
77
Retrospective analysis of the appendiceal neoplasms: sampling technique may influence neoplasm detection. 62
34911697 2021
78
[A Case Report of Carcinoma of the Appendix Which Was Diagnosed with Ascites One Year after Appendicitis Operation]. 62
35045467 2021
79
ASO Author Reflections: Use of a National Database to Determine the Optimal Surgical Intervention for a Rare Appendiceal Cancer. 62
34159475 2021
80
Risk of appendiceal neoplasm after interval appendectomy for complicated appendicitis: A systematic review and meta-analysis. 62
33640282 2021
81
[A Case of Internal Hernia Incarceration of a Mesenteric Defect following Laparoscopic Ileocecal Resection]. 62
35045522 2021
82
Cytoreductive Surgery with Hyperthermic Intrathoracic Chemotherapy for Patients with Intrapleural Dissemination of Peritoneal Surface Malignancies. 62
34263367 2021
83
Managing Recurrent Pseudomyxoma Peritonei in 430 Patients After Complete Cytoreduction and HIPEC: A Dilemma for Patients and Surgeons. 62
34041626 2021
84
AORTIC ARCH VARIANT AND COMMON CAROTID ARTERY AGENESIS. 62
35333461 2021
85
Peritoneal Spread of Low-grade Appendiceal Tumours - 2 Days of Early Postoperative Intra-peritoneal Chemotherapy Are Enough. 62
34732427 2021
86
A rare case of synchronous appendiceal and cecal cancer. 62
34264499 2021
87
Repeated cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy in patients with peritoneal carcinomatosis: A retrospective cohort study. 62
34584682 2021
88
Oncological Safety and Potential Cost Savings of Routine Versus Selective Histopathological Examination Following Appendectomy: Results of the Multicenter, Prospective, Cross-Sectional FANCY Study. 62
35072428 2021
89
Immunohistochemistry features and molecular pathology of appendiceal neoplasms. 62
33569997 2021
90
Organoid Platform in Preclinical Investigation of Personalized Immunotherapy Efficacy in Appendiceal Cancer: Feasibility Study. 62
34210684 2021
91
Treatment of advanced pseudomyxoma peritonei using cytoreductive surgery including total gastrectomy and perioperative chemotherapy. 62
33914912 2021
92
[Pathological diagnosis and clinical significance of appendiceal epithelial neoplasms]. 62
34530571 2021
93
Pseudomyxoma peritonei of appendiceal origin mimicking ovarian cancer - a case report with literature review. 62
34703416 2021
94
Low-grade Mucinous Appendiceal Neoplasm: a Tumor in Disguise of Appendicitis. 62
33570710 2021
95
Indications and outcomes for repeat cytoreductive surgery and heated intra-peritoneal chemotherapy in peritoneal surface malignancy. 62
33915487 2021
96
An extremely rare finding of goblet cell carcinoid of the appendix. A case report. 62
34636340 2021
97
Nomograms: Definitive Answer in the Appendiceal Cancer Treatment and Prognosis? 62
32281432 2021
98
A Nomogram for Predicting Lymph Nodal Metastases in Patients with Appendiceal Cancers: An Analysis of SEER Database. 62
31931634 2021
99
Phase II Trial of Adjuvant Dendritic Cell Vaccine in Combination with Celecoxib, Interferon-α, and Rintatolimod in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Metastases. 62
33400000 2021
100
Defining stage in mucinous tumours of the appendix with peritoneal dissemination: the importance of grading terminology: systematic review. 62
34355239 2021
101
Is interval appendectomy really needed? A closer look at neoplasm rates in adult patients undergoing interval appendectomy after complicated appendicitis. 62
32676725 2021
102
A Rare Presentation of Appendiceal Carcinoma. 62
34395144 2021
103
[Risk factors of peritoneal metastasis in primary appendiceal tumor]. 62
34289577 2021
104
Chemotherapy in the treatment of different histological types of appendiceal cancers: a SEER based study. 62
34225672 2021
105
Procedure of choice in a patient initially operated for a suspected epithelial appendiceal neoplasm. 62
34267916 2021
106
Lymph node positivity and association with long-term survival for different histologies of appendiceal cancer. 62
33902156 2021
107
A Predictive Model for Nodal Metastases in Patients With Appendiceal Cancers. 62
31361626 2021
108
Rising incidence of appendiceal neoplasms over time: Does pathological handling of appendectomy specimens play a role? 62
33667971 2021
109
Histologic and Racial/Ethnic Patterns of Appendiceal Cancer among Young Patients. 62
33795212 2021
110
Risk Factors for Appendiceal Cancer After Appendectomy. 62
33295195 2021
111
Mucosal prolapse syndrome-like inflammatory polyp protruding from the appendiceal orifice masquerading as an appendiceal neoplasm: A rare case report. 62
33386566 2021
112
Acquired Resistance to KRASG12C Inhibition in Cancer. 62
34161704 2021
113
The attitude and practice of general surgeons toward cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: A cross-sectional study. 62
34141418 2021
114
A case of pseudomyxoma peritonei successfully treated with trifluridine/tipiracil (TAS-102) and bevacizumab after palliative debulking surgery. 62
33752412 2021
115
Overexpression of ODF1 in Gastrointestinal Tract Neuroendocrine Neoplasms: a Novel Potential Immunohistochemical Biomarker for Well-differentiated Neuroendocrine Tumors. 62
32869188 2021
116
Mucinous Adenocarcinoma of the Appendix With Histologic Response to Neoadjuvant Chemotherapy: Review of Histologic and Clinical Spectrum of Epithelial Neoplastic Mucinous Lesions of the Appendix. 62
34161053 2021
117
Appendiceal adenocarcinoma found by surgery for acute appendicitis is associated with older age. 62
33934697 2021
118
Comparative study of mucinous and non-mucinous appendiceal neoplasms with peritoneal dissemination treated by cyoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). 62
33280949 2021
119
Twelve-Year Single Center Experience Shows Safe Implementation of Developed Peritoneal Surface Malignancy Treatment Protocols for Gastrointestinal and Gynecological Primary Tumors. 62
34069475 2021
120
[Analysis of correlation factors and risk prediction for acute appendicitis associated with appendiceal neoplasms]. 62
33915623 2021
121
Acute appendiceal diverticulitis: a case report. 62
33717385 2021
122
A case report of incarcerated inguinal hernia: Amyand's hernia with adenocarcinoma tumor. 62
33714896 2021
123
Quality analysis of operative reports and referral data for appendiceal neoplasms with peritoneal dissemination. 62
33190916 2021
124
Low-grade mucinous appendiceal neoplasm mimicking an ovarian lesion: A case report and review of literature. 62
33869611 2021
125
PIPAC-OX: A Phase I Study of Oxaliplatin-Based Pressurized Intraperitoneal Aerosol Chemotherapy in Patients with Peritoneal Metastases. 62
33148667 2021
126
Gut wrenching: cases of missed gastrointestinal tumors and their mimics on computed tomography. 62
33025217 2021
127
Improved chemosensitivity following mucolytic therapy in patient-derived models of mucinous appendix cancer. 62
33164812 2021
128
Mucinous appendiceal neoplasm: A case report. 62
33728318 2021
129
Retrospective case-control study to predict a potential underlying appendiceal tumor in an acute appendicitis context based on a CT-scoring system. 62
33454458 2021
130
Emergency laparoscopic ileocecal resection for a low-grade appendiceal mucinous neoplasm with impending rupture: A case report. 62
33609942 2021
131
Molecular and clinicopathological features of appendiceal mucinous neoplasms. 62
32821969 2021
132
Managing acute uncomplicated appendicitis in frail geriatric patients: A second hit may be too much. 62
33617197 2021
133
Is adjuvant chemotherapy beneficial for stage II-III goblet cell carcinoid/goblet cell adenocarcinoma of the appendix? 62
33360118 2021
134
Current Management of Appendiceal Neoplasms. 62
33770459 2021
135
Do the 'Eyes' have it? How good are surgeons at identifying appendicitis macroscopically? A retrospective study in NewZealand. 62
33767487 2021
136
A Low-Grade Appendiceal Mucinous Neoplasia and Neuroendocrine Appendiceal Collision Tumor: A Case Report and Review of the Literature. 62
33619239 2021
137
Appendiceal neoplasm incidence and mortality rates are on the rise in Australia. 62
33022181 2021
138
A retrospective analysis and literature review of neoplastic appendiceal mucinous lesions. 62
33573654 2021
139
Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei of Appendiceal Origin: A Single Center Experience. 62
34513915 2021
140
Women survive longer than men undergoing cytoreductive surgery and HIPEC for appendiceal cancer. 62
33930051 2021
141
The Role of Hyperthermic Intraperitoneal Chemotherapy for Non-colorectal Peritoneal Surface Malignancies. 62
32808135 2021
142
Long-term outcomes for patients with peritoneal acellular mucinosis secondary to low grade appendiceal mucinous neoplasms. 62
33092969 2021
143
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for colorectal and appendiceal peritoneal metastases - The Hong Kong experience and literature review. 62
32605790 2021
144
Impact of signet ring cells on overall survival in peritoneal disseminated appendix cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. 62
33272738 2021
145
Clinicopathological Characteristics of Low-Grade Appendiceal Mucinous Neoplasm. 62
33691316 2021
146
Case Report: The importance of examining colon and rectum in patients with appendiceal cancer. 62
35284062 2021
147
Primary appendiceal Burkitt's lymphoma presenting as acute appendicitis: An extremely rare case report and review of the literatture. 62
33363721 2021
148
Laparoscopic surgery for appendiceal cancer with intestinal malrotation in an adult: A case report. 62
33388515 2021
149
Leiomyosarcoma mimicking acute appendicitis: a cautionary tale! 62
33495185 2021
150
Appendiceal cancer leading to intussusception detected incidentally during follow-up for Peutz-Jeghers syndrome. 62
33034013 2020
151
Molecular Characterization of Appendiceal Goblet Cell Carcinoid. 62
33037134 2020
152
Elevated prevalence of nodal positivity in carcinoid tumours of the appendix smaller than 2 cm has a negative impact on overall survival. 62
33463877 2020
153
[A Case of Locally Advanced Appendiceal Cancer with Radical Resection after CAPOX plus Bevacizumab]. 62
33468821 2020
154
Preoperative Factors Associated with Appendiceal Tumors in Nonelective Appendectomy. 62
32678991 2020
155
[A Case Report with R0 Resection for Locally Advanced Appendiceal Cancer Invading to the Right External Iliac Vessels]. 62
33468944 2020
156
Spectrum of Somatic Cancer Gene Variations Among Adults With Appendiceal Cancer by Age at Disease Onset. 62
33295976 2020
157
Implications of Postoperative Complications for Survival After Cytoreductive Surgery and HIPEC: A Multi-Institutional Analysis of the US HIPEC Collaborative. 62
32696303 2020
158
Invasive Mucinous Neoplasm of the Appendix Masquerading as Recurrent Urinary Tract Infections: a Case Report. 62
32716041 2020
159
Clinical Implications of Genetic Signatures in Appendiceal Cancer Patients with Incomplete Cytoreduction/HIPEC. 62
32705511 2020
160
Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Is Not Associated with Prohibitive Complications: Results of a Multiinstitutional Retrospective Study. 62
32318945 2020
161
A Benign Appendiceal-Colonic Fistula, Diagnosed and Managed Laparoscopically: A Case Report. 62
33162549 2020
162
Advances with pharmacotherapy for peritoneal metastasis. 62
32783786 2020
163
Incidence and risk factors for fluorescence abnormalities on near-infrared imaging using indocyanine green in stapled functional end-to-end anastomosis in laparoscopic colectomy. 62
32577872 2020
164
Appendicitis mimicking the CT appearance of an appendiceal mucinous neoplasm. 62
33708342 2020
165
Incidental low grade mucinous neoplasm of appendix in pregnancy: A case report & literature review. 62
33204412 2020
166
Mucinous appendiceal neoplasms with or without pseudomyxoma peritonei: a review. 62
32761790 2020
167
Implications of the presence of the vermiform appendix inside an inguinal hernia (Amyand's hernia): a systematic review of the literature. 62
32451789 2020
168
Laparoscopic hyperthermic intraperitoneal chemotherapy for appendiceal tumors. 62
31997552 2020
169
Increased Risk of Neoplasms in Adult Patients Undergoing Interval Appendectomy. 62
32054244 2020
170
Early-Onset Appendiceal Cancer Survival by Race or Ethnicity in the United States. 62
32540351 2020
171
Updates in Appendix Pathology: The Precarious Cutting Edge. 62
32773195 2020
172
Outcomes of neoadjuvant chemotherapy before CRS-HIPEC for patients with appendiceal cancer. 62
32383206 2020
173
Predictors of lymph node metastases in patients with mucinous appendiceal adenocarcinoma. 62
32346885 2020
174
Appendiceal neoplasms and histological involvement of the mesoappendix: A case series. 62
32577233 2020
175
Appendiceal cancer : a review of the literature. 62
33094592 2020
176
[Outcome of Icelandic patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC) abroad]. 62
32608356 2020
177
Appendicitis is a Severe Disease in Elderly Patients: A Twenty-Year Audit. 62
32863702 2020
178
Interval laparoscopic appendectomy after antibiotic therapy for appendiceal abscess in elderly patients. 62
31621202 2020
179
The influence of platelet-rich plasma (PRP) on colonic anastomosis healing impaired by intraperitoneal 5-flourouracil application. An experimental study. 62
32638844 2020
180
Predicting Aborted Hyperthermic Intraperitoneal Chemotherapy (AHIPEC) with Preoperative Tumor and Inflammatory Markers in Potentially Resectable Appendiceal Cancer Patients with Peritoneal Carcinomatosis. 62
31980984 2020
181
Improved Outcome Prediction for Appendiceal Pseudomyxoma Peritonei by Integration of Cancer Cell and Stromal Transcriptional Profiles. 62
32521738 2020
182
Impact of Referral Center Pathology Review on Diagnosis and Management of Patients With Appendiceal Neoplasms. 62
31714810 2020
183
The Chicago Consensus on peritoneal surface malignancies: Management of appendiceal neoplasms. 62
32282073 2020
184
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms. 62
32285275 2020
185
Repeat cytoreductive surgery with or without intraperitoneal chemotherapy for recurrent epithelial appendiceal neoplasms. 62
32020757 2020
186
Impact of adjuvant chemotherapy on outcomes in appendiceal cancer. 62
32189461 2020
187
[Retrospective investigation of patients receiving additional surgery after endoscopic non-curative resection for early colorectal cancer]. 62
32842429 2020
188
Blood-Based Next-Generation Sequencing Analysis of Appendiceal Cancers. 62
31784493 2020
189
Cell-free Circulating Tumor DNA Variant Allele Frequency Associates with Survival in Metastatic Cancer. 62
31852833 2020
190
The prognostic relevance of histologic subtype in appendiceal adenocarcinoma. 62
31668980 2020
191
Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin. 62
31720933 2020
192
Predictors of Anastomotic Failure After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Does Technique Matter? 62
31659645 2020
193
Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin. 62
31848812 2020
194
ASO Author Reflections: Patient-Reported Outcomes of Mucinous Appendiceal Cancer Improve with Oxaliplatin HIPEC. 62
31720929 2020
195
SATB2 protein expression by immunohistochemistry is a sensitive and specific marker of appendiceal and rectosigmoid well differentiated neuroendocrine tumours. 62
31595536 2020
196
Rational application of targeted therapeutics in mucinous colon/appendix cancers with positive predictive factors. 62
31958897 2020
197
The SIFIPAC/WSES/SICG/SIMEU guidelines for diagnosis and treatment of acute appendicitis in the elderly (2019 edition). 62
32156296 2020
198
Burkitt Leukemia Presenting as Acute Appendicitis: A Case Report and Literature Review. 62
32094318 2020
199
Evaluation of repeat cytoreductive surgery and heated intraperitoneal chemotherapy for patients with recurrent peritoneal carcinomatosis from appendiceal and colorectal cancers: a multicentre Canadian study 62
32080999 2020
200
"Obscure" Appendiceal Orifice Polyps Can Be Challenging to Identify by Colonoscopy. 62
32095121 2020
201
Primary Appendiceal Adenocarcinoma Presenting with Hematochezia due to the Invading Tumor in the Sigmoid Colon. 62
32963874 2020
202
Preoperative Risk Score for Predicting Incomplete Cytoreduction: A 12-Institution Study from the US HIPEC Collaborative. 62
31602579 2020
203
An Unusual Case of Acute Appendicitis due to Metastatic Prostatic Adenocarcinoma. 62
32908762 2020
204
Risk factors for appendiceal neoplasm and malignancy among patients with acute appendicitis. 62
31811385 2020
205
Synchronous primary neuroendocrine and mucinous epithelial tumors present in the same appendix. Case report of 2 patients. 62
32035310 2020
206
Splenic metastases - hematogenous disease or invasive peritoneal implants? Case reports of two patients. 62
32554282 2020
207
Mucinous appendiceal adenocarcinomas: a diagnostic challenge. 62
31988709 2020
208
Multi-origin mucinous neoplasm: Should we prophylactically remove the appendix in the setting of mucinous ovarian tumors? 62
31901742 2020
209
Lobaplatin-Based Hyperthermic Intraperitoneal Chemotherapy for Patients with Peritoneal Metastasis from Appendiceal and Colorectal Cancer: Safety and Efficacy Profiles. 62
33262658 2020
210
Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection. 62
31368017 2020
211
Utilization and Treatment Patterns of Cytoreduction Surgery and Intraperitoneal Chemotherapy in the United States. 62
31187369 2020
212
Impact of nonappendiceal cancer-specific death on overall survival: a competing risk analysis. 62
31749380 2019
213
Intraoperative packed red blood cell transfusion (iPRBT) and PCI-normalised iPRBT rates (iPRBT/PCI ratio) negatively affect short- and long-term outcomes of patients undergoing cytoreductive surgery and intraperitoneal chemotherapy - An analysis of 880 patients. 62
31444027 2019
214
Intraperitoneal mitomycin C improves survival compared to cytoreductive surgery alone in an experimental model of high-grade pseudomyxoma peritonei. 62
31541325 2019
215
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastases. 62
31239549 2019
216
[Appendix Cancer with Long-Term Survival after Multimodality Therapy-A Case Report]. 62
32156998 2019
217
The American Society of Colon and Rectal Surgeons, Clinical Practice Guidelines for the Management of Appendiceal Neoplasms. 62
31725580 2019
218
Safety and cost analysis of selective histopathological examination following appendicectomy and cholecystectomy (FANCY study): protocol and statistical analysis plan of a prospective observational multicentre study. 62
31874901 2019
219
Early recurrence in peritoneal metastasis of appendiceal neoplasm: Survival and prognostic factors. 62
31253546 2019
220
Appendiceal Adenocarcinoma Associated With Ulcerative Colitis. 62
32309470 2019
221
Correlation of molecular and morphological features of appendiceal epithelial neoplasms. 62
31111538 2019
222
Obstruction-Free Survival Following Operative Intervention for Malignant Bowel Obstruction in Appendiceal Cancer. 62
31190209 2019
223
Outcomes from cytoreduction and hyperthermic intraperitoneal chemotherapy for appendiceal epithelial neoplasms. 62
30685879 2019
224
Metastatic appendiceal cancer treated with Yttrium 90 radioembolization and systemic chemotherapy: A case report. 62
31608143 2019
225
Appendiceal cancer masked as inflammatory appendicitis in the elderly, not an uncommon presentation (Surveillance Epidemiology and End Results (SEER)-Medicare Analysis). 62
31309554 2019
226
History of pseudomyxoma peritonei from its origin to the first decades of the twenty-first century. 62
31572561 2019
227
Risk of appendiceal cancer in patients undergoing appendectomy for appendicitis in the era of increasing nonoperative management. 62
31270824 2019
228
Systemic chemotherapy and survival in patients with metastatic low-grade appendiceal mucinous adenocarcinoma. 62
31236958 2019
229
AMG 510 First to Inhibit "Undruggable" KRAS. 62
31189530 2019
230
Appendiceal mucocele secondary to torsion in an asymptomatic patient. 62
31428310 2019
231
The Understated Malignancy Potential of Nonoperative Acute Appendicitis. 62
31405413 2019
232
Low-grade Appendiceal Mucinous Neoplasm in the Context of Acute Appendicitis. 62
31528511 2019
233
Selection and Characteristics of Patients with Peritoneal Dissemination from Appendiceal Cancer with Exceptional/Poor Survival After CRS/HIPEC. 62
31041628 2019
234
Who Undergoes Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Appendiceal Cancer? An Analysis of the National Cancer Database. 62
30772678 2019
235
Factors influencing long-term survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei originating from appendiceal neoplasms. 62
31183454 2019
236
Mucinous appendiceal neoplasms: classification, imaging, and HIPEC. 62
30610247 2019
237
Survival outcomes of appendiceal mucinous neoplasms by histological type and stage: Analysis of 266 cases in a multicenter collaborative retrospective clinical study. 62
31131358 2019
238
Introducing the eighth edition of the tumor-node-metastasis classification as relevant to colorectal cancer, anal cancer and appendiceal cancer: a comparison study with the seventh edition of the tumor-node-metastasis and the Japanese Classification of Colorectal, Appendiceal, and Anal Carcinoma. 62
30608547 2019
239
Spectrum of computed tomography manifestations of appendiceal neoplasms: acute appendicitis and beyond. 62
31069398 2019
240
Autoantibody to transcriptional intermediary factor-1β as a myositis-specific antibody: clinical correlation with clinically amyopathic dermatomyositis or dermatomyositis with mild myopathy. 62
30120913 2019
241
[CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY (HIPEC) FOR PERITONEAL METASTASIS OF GASTRO-INTESTINAL ORIGIN]. 62
31032561 2019
242
Risk of Appendiceal Neoplasm in Periappendicular Abscess in Patients Treated With Interval Appendectomy vs Follow-up With Magnetic Resonance Imaging: 1-Year Outcomes of the Peri-Appendicitis Acuta Randomized Clinical Trial. 62
30484824 2019
243
Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei. 62
30611664 2019
244
Gastrointestinal: Successful endoscopic submucosal dissection assisted with endoloop for early appendiceal cancer that had everted into the cecal lumen. 62
30302827 2019
245
[Multivisceral resection with and without HIPEC in cancer surgery]. 62
30361743 2019
246
Outcomes in Peritoneal Dissemination from Signet Ring Cell Carcinoma of the Appendix Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. 62
30523470 2019
247
Appendiceal Malignancy: The Hidden Risks of Nonoperative Management for Acute Appendicitis. 62
30819303 2019
248
Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study. 62
30414038 2019
249
Combined Mucinous and Neuroendocrine Tumours of the Appendix Managed with Surgical Cytoreduction and Oxaliplatin-based Hyperthermic Intraperitoneal Chemotherapy. 62
30911451 2019
250
Total pelvic exenterative surgery in patients with peritoneal metastases from appendiceal neoplasms. A case series of 2 patients. 62
31756689 2019
251
Appendiceal neoplasm risk associated with complicated acute appendicitis-a population based study. 62
30242478 2019
252
Tubulo-villous adenoma of the appendix: A case report and review of the literature. 62
31349156 2019
253
Different distribution of mucosal-associated invariant T cells within the human cecum and colon. 62
31114440 2019
254
Mantle cell lymphoma-rare differential diagnosis of a tumor in the vermiform appendix. 62
30697413 2019
255
Exploring the Use of Pegylated Liposomal Doxorubicin (Caelyx®) as Pressurized Intraperitoneal Aerosol Chemotherapy. 62
31293417 2019
256
[A Case of Appendiceal Cancer Wherein the Abdominal Abscess Ruptured into the Urinary Bladder Owing to Obstructive Appendicitis]. 62
30692497 2018
257
Clinical significance of appendiceal diverticulum: a significant marker for appendiceal neoplasia in Australian patients. 62
29785461 2018
258
Mucinous appendiceal neoplasms: pathologic classification, clinical implications, imaging spectrum and mimics. 62
29564494 2018
259
The role of appendectomy in patients with mucinous borderline ovarian tumors. 62
30145525 2018
260
Morbidity and mortality of synchronous hepatectomy with cytoreductive surgery/hyperthermic intraperitoneal chemotherapy (CRS/HIPEC). 62
30505581 2018
261
Leukocytoclastic vasculitis with late-onset Henoch-Schönlein purpura after trifluridine/tipiracil treatment. 62
30677817 2018
262
GNAS, GNAQ, and GNA11 alterations in patients with diverse cancers. 62
30204251 2018
263
Impact of Concomitant Urologic Intervention on Clinical Outcomes After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy. 62
29624505 2018
264
Appendiceal Neoplasms. 62
30186049 2018
265
Predictive value of peritoneal cancer index for survival in patients with mucinous peritoneal malignancies treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a single centre experience. 62
28679331 2018
266
Appendiceal intussusception requiring an ileocecectomy: a case report and comment on the optimal surgery. 62
30068337 2018
267
Preoperative Circulating Tumor DNA in Patients with Peritoneal Carcinomatosis is an Independent Predictor of Progression-Free Survival. 62
29948422 2018
268
Risk factors for appendiceal and colorectal peritoneal metastases. 62
29576463 2018
269
Peritoneal Metastases from Appendiceal Cancer. 62
29935689 2018
270
Psoas/iliacus muscle invasion from mucinous appendiceal neoplasm. Radiologic appearance and outcome of treatment in 3 patients. 62
29937165 2018
271
Peritoneal metastases invading the seminal vesicles: Radiologic appearance and outcome of treatment. 62
29428475 2018
272
Analysis of Appendiceal Neoplasms on 3544 Appendectomy Specimens for Acute Appendicitis: Retrospective Cohort Study of a Single Institution. 62
29947345 2018
273
Molecular Diagnostics in the Neoplasms of Small Intestine and Appendix: 2018 Update. 62
29776634 2018
274
Correction to: Tan et al., Diagnostic and therapeutic laparoscopy in assessment and management of patients with appendiceal neoplasms. 62
28967270 2018
275
[Diverticulosis and diverticulitis of the vermiform appendix. Report of a case and review of the literature]. 62
29730945 2018
276
Diagnostic and therapeutic laparoscopy in assessment and management of patients with appendiceal neoplasms. 62
28605985 2018
277
Single-center analysis of appendiceal neoplasms. 62
29731850 2018
278
Appendiceal diverticulosis: a harbinger of underlying primary appendiceal adenocarcinoma? 62
29755780 2018
279
A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal Tumors. 62
29331663 2018
280
A validated inductively coupled plasma mass spectrometry (ICP-MS) method for the quantification of total platinum content in plasma, plasma ultrafiltrate, urine and peritoneal fluid. 62
29414017 2018
281
[A Case Report of Appendiceal Cancer Complicated Appendicitis Treated with Single-Incision Laparoscopic Ileocecal Resection]. 62
29650824 2018
282
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian and gastrointestinal peritoneal carcinomatosis: results from a 7-year experience. 62
29755762 2018
283
SATB2 is a supportive marker for the differentiation of a primary mucinous tumor of the ovary and an ovarian metastasis of a low-grade appendiceal mucinous neoplasm (LAMN): A series of seven cases. 62
29487003 2018
284
Sister Mary Joseph Nodule as a Cutaneous Manifestation of Metastatic Appendiceal Adenocarcinoma: Case Report and Literature Review. 62
29719746 2018
285
Genomic Landscape of Appendiceal Neoplasms. 62
32913983 2018
286
Laparoscopic ileocecal resection can be applied for appendiceal cancer with an ileal fistula: A case report. 62
30343260 2018
287
Unusual case of intraluminal cecal recurrence of a low grade appendiceal mucinous neoplasm (LAMN)-Case report and brief literature review. 62
30149327 2018
288
Appendiceal neurofibroma with low-grade appendiceal mucinous neoplasm in neurofibromatosis type 1 patient: A case report. 62
30481737 2018
289
Surgical Resection with Neoadjuvant Chemotherapy for Locoregionally Recurrent Appendiceal Cancer Invading the External Iliac Vessels. 62
30155335 2018
290
Fitbit step counts during inpatient recovery from cancer surgery as a predictor of readmission. 62
29538623 2018
291
Expert Commentary on Appendiceal Neoplasms. 62
29112558 2017
292
Occult Appendiceal Neoplasms in Acute and Chronic Appendicitis: A Single-Institution Experience of 1793 Appendectomies. 62
29336758 2017
293
Circulating cell-free DNA in plasma of colorectal cancer patients - A potential biomarker for tumor burden. 62
29113658 2017
294
Low-grade appendiceal mucinous neoplasm and endometriosis of the appendix. 62
29258523 2017
295
Appendiceal Neoplasms. 62
29112557 2017
296
The histopathological classification, diagnosis and differential diagnosis of mucinous appendiceal neoplasms, appendiceal adenocarcinomas and pseudomyxoma peritonei. 62
28746986 2017
297
Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial Neoplasm. 62
28831698 2017
298
[A Case of Appendiceal Mucinous Adenocarcinoma Detected with a Bladder Tumor]. 62
29394656 2017
299
Pseudomyxoma peritonei due to low-grade appendiceal mucinous neoplasm with symptoms of inguinal hernia and uterine prolapse: a case report and review of the literature. 62
31149493 2017
300
Improved survival after retrieval of 12 or more regional lymph nodes in appendiceal cancer. 62
28734542 2017
301
Hyperthermic chemotherapy intra-abdominal laparoscopic approach: development of a laparoscopic model using CO2 recirculation system and clinical translation in peritoneal carcinomatosis. 62
28540790 2017
302
Role of SATB2 in distinguishing the site of origin in glandular lesions of the bladder/urinary tract. 62
28711650 2017
303
Adenocarcinoma of the appendix with extra-appendicular spread: Clinico-surgical and histologic analysis of 27 cases. 62
28549831 2017
304
Update on clinical trials in colorectal cancer peritoneal metastasis. 62
28142288 2017
305
Allogenic Blood Transfusion Is an Independent Predictor of Poorer Peri-operative Outcomes and Reduced Long-Term Survival after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: a Review of 936 Cases. 62
28560703 2017
306
Treatment of Peritoneal Dissemination in Stomach Cancer Patients With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Rationale and Design of the PERISCOPE Study. 62
28705789 2017
307
Neoplasms of the Appendix: Pictorial Review with Clinical and Pathologic Correlation. 62
28598731 2017
308
Kocher maneuver to facilitate cytoreduction within the foramen of Winslow. 62
28475818 2017
309
The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review. 62
28730323 2017
310
Mucinous appendiceal neoplasms: Incidence, diagnosis and surgical treatment. 62
28655402 2017
311
Experiences with cytoreduction surgery plus hyperthermic intraperitoneal chemotherapy in Taiwan. 62
28658135 2017
312
Clinical Benefit from Trametinib in a Patient with Appendiceal Adenocarcinoma with a GNAS R201H Mutation. 62
28868010 2017
313
Perioperative systemic chemotherapy for peritoneal mucinous appendiceal carcinomas treated with cytoreductive surgery & HIPEC. 62
28730790 2017
314
Cancers of the appendix. Case report and literatures review. 62
28504243 2017
315
Appendiceal neoplasm presenting as intussusception in an adult - a video vignette. 62
28235158 2017
316
Histological Subtype Remains a Significant Prognostic Factor for Survival Outcomes in Patients With Appendiceal Mucinous Neoplasm With Peritoneal Dissemination. 62
28267002 2017
317
When and When Not to Perform a Right Colon Resection with Mucinous Appendiceal Neoplasms. 62
27770344 2017
318
Radical appendectomy as an alternative to right colon resection in patients with epithelial appendiceal neoplasms. 62
28317590 2017
319
Metastasis to the appendix from adenocarcinoma of the ascending colon: A case report. 62
28296772 2017
320
Amyand's hernia containing an appendiceal goblet cell carcinoid tumour. 62
28302663 2017
321
Role of CRS and HIPEC in appendiceal and colorectal malignancies: Indian experience. 62
28393331 2017
322
Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis. 62
28280620 2017
323
Pulmonary toxicity after intraperitoneal mitomycin C: a case report of a rare complication of HIPEC. 62
28219391 2017
324
Acute appendicitis, inflammatory appendiceal mass and the risk of a hidden malignant tumor: a systematic review of the literature. 62
28286544 2017
325
Overinterpretation is common in pathological diagnosis of appendix cancer during patient referral for oncologic care. 62
28591173 2017
326
Two concurrent appendiceal neoplasms in an elderly patient: A case report. 62
28988021 2017
327
[Mixed adenoneuroendocrine carcinoma (MANEC) of the gastrointestinal tract]. 62
28325058 2017
328
Diarrhea Concealing a Duodenal-Cecal Fistula Secondary to Appendiceal Mucinous Neoplasm. 62
28138447 2017
329
Curative Surgical Resection as a Component of Multimodality Therapy for Peritoneal Metastases from Goblet Cell Carcinoids. 62
27401448 2016
330
Phase IB Study of Vemurafenib in Combination with Irinotecan and Cetuximab in Patients with Metastatic Colorectal Cancer with BRAFV600E Mutation. 62
27729313 2016
331
Pseudomyxoma peritonei of a mature ovarian teratoma caused by mismatch repair deficiency in a patient with Lynch syndrome: a case report. 62
27938333 2016
332
Adverse Events Postoperatively Had No Impact on Long-Term Survival of Patients Treated with Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Appendiceal Cancer with Peritoneal Metastases. 62
27338748 2016
333
Pseudomyxoma Peritonei of Extra-Appendiceal Origin: A Comparative Study. 62
27352203 2016
334
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: long-term results at St George Hospital, Australia. 62
26179296 2016
335
Goblet cell carcinoids of the appendix: Tumor biology, mutations and management strategies. 62
27830037 2016
336
Elevated risk of subsequent malignancies in patients with appendiceal cancer: A population-based analysis. 62
27595862 2016
337
Impact of Mucinous Histology on the Prognosis of Stage I-III Adenocarcinomas of the Appendix: a Population-Based, Propensity Score-Matched Analysis. 62
27120448 2016
338
Using Literature Review and Structured Hybrid Electronic/ Manual Mortality Review to Identify System-Level Improvement Opportunities to Reduce Colorectal Cancer Mortality. 62
27301833 2016
339
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Pseudomyxoma Peritonei and Appendix Tumours. 62
27065707 2016
340
Prophylactic hyperthermic intraperitoneal chemotherapy in patients with epithelial appendiceal neoplasms. 62
27050712 2016
341
Recommendations in the management of epithelial appendiceal neoplasms and peritoneal dissemination from mucinous tumours (pseudomyxoma peritonei). 62
26489426 2016
342
Preoperative CT and MRI prediction of non-resectability in patients treated for pseudomyxoma peritonei from mucinous appendiceal neoplasms. 62
26856956 2016
343
Prognostic Molecular Subtypes of Low-Grade Cancer of the Appendix. 62
26821970 2016
344
Ileocecal Intussusception Caused by an Appendiceal Neoplasm. 62
26831058 2016
345
Beyond appendicitis; radiologic review of unusual and rare pathology of the appendix. 62
27039327 2016
346
Comparison of long-term oncological outcomes of appendiceal cancer and colon cancer: A multicenter retrospective study. 62
26979639 2016
347
A giant mucinous cystadenocarcinoma of the appendix: a case report and review of the literature. 62
26945579 2016
348
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with liver involvement. 62
26804119 2016
349
Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms. 62
26429720 2016
350
Conditional Survival After Cytoreductive Surgery with Heated Intraperitoneal Chemotherapy for Low- and High-Grade Appendiceal Primaries. 62
26289808 2016
351
Peritoneal dissemination from high-grade appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). 62
26941979 2016
352
Surgical technology and pharmacology of hyperthermic perioperative chemotherapy. 62
26941982 2016
353
Chronic inflammation masquerading as an appendiceal tumour with peritoneal metastasis: the challenge of diagnosis and the lessons learnt. 62
26917796 2016
354
Synchronous Renal Cell Carcinoma and Gastrointestinal Malignancies. 62
26904353 2016
355
[Carcinoid of the Appendix Goblet Cells Metastasize to the Orbit - a Clinical Case Report and Review of the Literature]. 62
27296408 2016
356
Appendiceal Adenocarcinoma Presenting as a Rectal Polyp. 62
27403098 2016
357
Diagnosis and Treatment of Mucinous Appendiceal Neoplasm Presented as Acute Appendicitis. 62
27066284 2016
358
Prognostic factors for survival in advanced appendiceal cancers. 62
27802196 2016
359
The impact of stage, grade, and mucinous histology on the efficacy of systemic chemotherapy in adenocarcinomas of the appendix: Analysis of the National Cancer Data Base. 62
26506400 2016
360
Corrigendum to "Diagnosis and Treatment of Mucinous Appendiceal Neoplasm Presented as Acute Appendicitis". 62
27957365 2016
361
Management of Appendix Cancer. 62
26648795 2015
362
Chemotherapy improves survival in appendiceal cancer. 62
26549587 2015
363
Identification of Differentially Expressed miRNAs in Appendiceal Mucinous Cystadenocarcinoma from Mucinous Cystadenoma. 62
26807210 2015
364
Molecular inimitability amongst tumors: implications for precision cancer medicine in the age of personalized oncology. 62
26418953 2015
365
Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers: A Retrospective Review. 62
25663593 2015
366
Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis. 62
26493405 2015
367
Pressurized intraperitoneal aerosol chemotherapy as an innovative approach to treat peritoneal carcinomatosis. 62
26277656 2015
368
Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center. 62
26143715 2015
369
Perforated appendiceal diverticulitis associated with appendiceal neurofibroma in neurofibromatosis type 1. 62
26361430 2015
370
Persistent Coughing as the First Symptom of Primary Mucinous Appendiceal Adenocarcinoma. 62
26124915 2015
371
Phase I dose-escalation study of cabazitaxel administered in combination with gemcitabine in patients with metastatic or unresectable advanced solid malignancies. 62
26020806 2015
372
Management and Outcomes of Hospitalized Patients With Primary Neuroendocrine Tumor and Non-Neuroendocrine Tumor Appendiceal Cancers in the United States. 62
28983329 2015
373
Impact of distal pancreatectomy on outcomes of peritoneal surface disease treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. 62
25120249 2015
374
Peritoneal surface disease with synchronous hepatic involvement treated with Cytoreductive Surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC). 62
25120252 2015
375
Institutional learning curve of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for peritoneal malignancies. 62
25377640 2015
376
Peritoneal surface disease (PSD) from appendiceal cancer treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC): overview of 481 cases. 62
25319583 2015
377
Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms. 62
25908915 2015
378
The rise in appendiceal cancer incidence: 2000-2009. 62
25560182 2015
379
Trends in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of synchronous peritoneal carcinomatosis of colorectal origin in the Netherlands. 62
25680955 2015
380
Multidisciplinary perspective on the management of appendiceal adenocarcinoma: case review of 10 patients from a university hospital and current considerations. 62
25497140 2015
381
Is there truly an oncologic indication for interval appendectomy? 62
25543294 2015
382
[Vesico-appendiceal fistula caused by appendiceal cancer: a case report]. 62
25918266 2015
383
[A case of appendix cancer treated as cancer of unknown primary origin]. 62
25743145 2015
384
Predictive and prognostic survival factors in peritoneal carcinomatosis from appendiceal cancer after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. 62
24986239 2014
385
Clinicopathologic and molecular analysis of disseminated appendiceal mucinous neoplasms: identification of factors predicting survival and proposed criteria for a three-tiered assessment of tumor grade. 62
24633196 2014
386
Does obesity affect outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion for disseminated mucinous appendiceal neoplasms? 62
24916747 2014
387
Evaluation of a new staging classification and a Peritoneal Surface Disease Severity Score (PSDSS) in 229 patients with mucinous appendiceal neoplasms with or without peritoneal dissemination. 62
24898451 2014
388
Oxaliplatin-based versus irinotecan-based hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with peritoneal metastasis from appendiceal and colorectal cancer: a retrospective analysis. 62
25369730 2014
389
[No recurrent case of the combination of surgical management with chemotherapy]. 62
25731562 2014
390
Safety of repeated cell-free and concentrated ascites reinfusion therapy for malignant ascites from gastrointestinal cancer. 62
25279205 2014
391
Appendiceal skip inflammation and ulcerative colitis. 62
24705639 2014
392
Phase II trial of adjuvant oral thalidomide following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface disease from colorectal/appendiceal cancer. 62
24452995 2014
393
Focal fatty infiltration in Segment IV of the liver mimicking peritoneal carcinomatosis on CT and MR imaging. 62
24973944 2014
394
Low Grade Appendiceal Mucinous Neoplasm with Pseudomyxoma Peritonei: An Enigma for Pathologist. 62
29699361 2014
395
Care of the open abdomen after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal surface malignancies. 62
24969254 2014
396
[Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal and appendiceal origin]. 62
25095601 2014
397
Goblet cells carcinoid with mucinous adenocarcinoma of the vermiform appendix: a step towards the unitary intestinal stem cell theory? 62
24943968 2014
398
Clinical and CT findings in appendiceal diverticulitis. 62
24440390 2014
399
Single-incision laparoscopic cecectomy for low-grade appendiceal mucinous neoplasm after laparoscopic rectectomy. 62
24868331 2014
400
Progression of peritoneal adenomucinosis to the scrotum: a rare occurrence treated with cytoreductive surgery and hyperthermic chemoperfusion of the scrotum in two patients. 62
25100893 2014
401
[Peritoneal pseudomyxoma: an overview emphasizing pathological assessment and therapeutic strategies]. 62
24630633 2014
402
Surgical outcomes of hyperthermic intraperitoneal chemotherapy: analysis of the american college of surgeons national surgical quality improvement program. 62
24352601 2014
403
Combination of CT imaging and endoscopy in diagnosis of appendicovesical fistula caused by appendiceal adenocarcinoma. 62
25080116 2014
404
Adenocarcinomas of appendix: a rare tumor. Two case reports. 62
25524188 2014
405
The role of VEGFR-2 expression in outcomes and survival of patients with peritoneal carcinomatosis from appendiceal cancer. 62
24075030 2013
406
Appendiceal mucosal Schwann cell proliferation: a putative histologic marker of appendiceal diverticular disease. 62
23842004 2013
407
Repeated cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from appendiceal cancer: analysis of survival outcomes. 62
24007834 2013
408
Obesity and peritoneal surface disease: outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for appendiceal and colon primary tumors. 62
23800899 2013
409
Low-grade appendiceal neoplasm presenting as a volvulus of the cecum. 62
24759968 2013
410
Outcomes of Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients older than 70 years; survival benefit at considerable morbidity and mortality. 62
23780382 2013
411
Outcomes for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the elderly. 62
23827047 2013
412
Activity ex vivo of cytotoxic drugs in patient samples of peritoneal carcinomatosis with special focus on colorectal cancer. 62
24063788 2013
413
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in Asian patients: 100 consecutive patients in a single institution. 62
23504144 2013
414
Iterative cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for recurrent peritoneal metastases. 62
23737041 2013
415
Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects β-catenin distribution. 62
23743566 2013
416
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis: the Danish experience. 62
23458368 2013
417
Neuroendocrine tumour, mucinous adenocarcinoma and signet-ring cell carcinoma of the appendix: three cases and review of literature. 62
24426597 2013
418
Secondary cytoreductive surgery and peri-operative intraperitoneal chemotherapy for peritoneal recurrence of colorectal and appendiceal peritoneal carcinomatosis following prior primary cytoreduction. 62
23280508 2013
419
Surveillance MR imaging is superior to serum tumor markers for detecting early tumor recurrence in patients with appendiceal cancer treated with surgical cytoreduction and HIPEC. 62
23456382 2013
420
Assessment of neoadjuvant chemotherapy on operative parameters and outcome in patients with peritoneal dissemination from high-grade appendiceal cancer. 62
23456383 2013
421
Xanthogranulomatous inflammation in terminal ileum presenting as an appendiceal mass: case report and review of the literature. 62
23614133 2013
422
Risk-reducing appendectomy and the elimination of BRCA1-associated intraperitoneal cancer. 62
23552812 2013
423
Mucinous neoplasms of the appendix: a current comprehensive clinicopathologic and imaging review. 62
23439060 2013
424
Heated intraperitoneal chemotherapy in appendiceal cancer treatment. 62
23372101 2013
425
Pulmonary metastasis from a low grade mucinous appendiceal neoplasm. 62
23250037 2013
426
[Rectal goblet cell carcinoid. Primary tumor or metastasis?]. 62
22555364 2013
427
Goblet cell carcinoid neoplasm of the appendix: clinical and CT features. 62
23088880 2013
428
Laparoscopic diagnosis of adenocarcinoma of the appendix mimicking serous papillary adenocarcinoma of the peritoneum. 62
24383020 2013
429
Extranodal Rosai-Dorfman disease involving appendix and mesenteric nodes with a protracted course: report of a rare case lacking relationship to IgG4-related disease and review of the literature. 62
24228122 2013
430
Clinicopathological study of 25 cases of diverticular disease of the appendix: experience from farwaniya hospital. 62
24224113 2013
431
Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. 62
23124619 2013
432
Neoplasms of the appendix: current treatment guidelines. 62
23116580 2012
433
[Acute abdomen due to perforated appendicular mucocele]. 62
23383528 2012
434
Surgical management of primary appendiceal malignancy. 62
22515312 2012
435
Management of the acute appendix mass: a survey of surgical practice. 62
23240283 2012
436
Current status and future directions in appendiceal cancer with peritoneal dissemination. 62
23021718 2012
437
Outcomes of repeat cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal surface malignancy. 62
22634117 2012
438
Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy. 62
22750758 2012
439
Delay of cytoreductive surgery and heated intraperitoneal chemotherapy in patients with appendiceal neoplasm. 62
22748531 2012
440
Significance of acquired diverticular disease of the vermiform appendix: a marker of regional neoplasms? 62
22461655 2012
441
Radiological manifestations of metastasis to the ovary. 62
22745289 2012
442
Aggressive management of peritoneal carcinomatosis from mucinous appendiceal neoplasms. 62
22302270 2012
443
Importance of histologic subtype in the staging of appendiceal tumors. 62
22302267 2012
444
Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomes. 62
22342786 2012
445
Early postoperative intraperitoneal chemotherapy following cytoreductive surgery for appendiceal mucinous neoplasms with isolated peritoneal metastasis. 62
22426264 2012
446
[Mucinous neoplasms of the vermiform appendix, Pseudomyxoma peritonei, and the new WHO classification]. 62
22179200 2012
447
Mucinous appendiceal neoplasms. Do we all speak the same language? 62
22300121 2012
448
Periappendiceal abscess mimicking appendiceal cancer. 62
22318074 2012
449
Right hemicolectomy is not routinely indicated in pseudomyxoma peritonei. 62
22369825 2012
450
Systemic Chemotherapy prior to Cytoreductive Surgery and HIPEC for Carcinomatosis from Appendix Cancer: Impact on Perioperative Outcomes and Short-Term Survival. 62
22899903 2012
451
Surgical results of patients with peritoneal carcinomatosis treated with cytoreductive surgery using a new technique named aqua dissection. 62
22666235 2012
452
Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer. 62
21748246 2012
453
The role of cytoreductive surgery and heated intraperitoneal chemotherapy (CRS/HIPEC) in patients with high-grade appendiceal carcinoma and extensive peritoneal carcinomatosis. 62
21701929 2012
454
Ureteral stenting in cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy as a routine procedure: evidence and necessity. 62
22868250 2012
455
Carcinoma involving the gallbladder: a retrospective review of 23 cases - pitfalls in diagnosis of gallbladder carcinoma. 62
22284391 2012
456
Low-grade appendiceal mucinous neoplasm with disseminated peritoneal adenomucinosis involving the uterus, mimicking primary mucinous endometrial adenocarcinoma: a case report. 62
21733040 2011
457
[Observation of the appendiceal neoplasm and acute cholecystitis]. 62
22295557 2011
458
Impact of surgical and clinical factors on the pharmacology of intraperitoneal doxorubicin in 145 patients with peritoneal carcinomatosis. 62
21621952 2011
459
Changes induced by surgical and clinical factors in the pharmacology of intraperitoneal mitomycin C in 145 patients with peritoneal carcinomatosis. 62
20857115 2011
460
Subperitoneal adenomucinosis following proctocolectomy for ulcerative colitis. 62
21698710 2011
461
Ki-ras gene mutations are invariably present in low-grade mucinous tumors of the vermiform appendix. 62
21443421 2011
462
PET/CT appearance of appendiceal adenocarcinoma. 62
21552034 2011
463
Peritoneal carcinomatosis from appendiceal cancer: early adequate therapeutic management for long-term survival. 62
21487964 2011
464
Surgical cytoreduction and survival in appendiceal cancer peritoneal carcinomatosis: an evaluation of 46 consecutive patients. 62
21491165 2011
465
Primary appendiceal mucinous adenocarcinoma in two first-degree relatives: case report and review. 62
21542938 2011
466
Is malignant dedifferentiation for mucinous appendiceal neoplasms a valid phenomenon or merely histopathologic ambiguity? 62
21530846 2011
467
Carcinoid tumour of the appendix: problems of diagnosis and treatment. 62
21696065 2011
468
Duplicated appendix complicated by appendiceal cancer. 62
21218095 2011
469
Mucinous metaplasia of the fallopian tube: a diagnostic pitfall mimicking metastasis. 62
21131836 2011
470
Clinicopathological analysis of primary epithelial appendiceal neoplasms. 62
19851895 2010
471
[Giant appendiceal mucocele during laparotomy for acute abdomen. Report of a case and brief review]. 62
21232194 2010
472
Indication of peritonectomy for peritoneal dissemination. 62
21224556 2010
473
Epithelial neoplasms of the appendix. 62
21043814 2010
474
Neoadjuvant FOLFOX chemotherapy in 34 consecutive patients with mucinous peritoneal carcinomatosis of appendiceal origin. 62
20737420 2010
475
A case of appendiceal Crohn's disease in which a laparoscopic appendectomy was performed. 62
21309418 2010
476
Survival of patients with pseudomyxoma peritonei treated by serial debulking. 62
19519686 2010
477
Establishment and characterization of a murine xenograft model of appendiceal mucinous adenocarcinoma. 62
20586814 2010
478
Clinical utility of elevated tumor markers in patients with disseminated appendiceal malignancies treated by cytoreductive surgery and HIPEC. 62
20561764 2010
479
Primary appendiceal carcinoma--epidemiology, surgery and survival: results of a German multi-center study. 62
20561765 2010
480
Unusual presentation for primary appendiceal lymphoma: A case report. 62
23133274 2010
481
[Mucocele of the appendix: an unusual finding in a patient with ulcerative colitis]. 62
21167104 2010
482
Appendiceal carcinoid and mucinous cystadenoma in renal transplant recipients: case reports. 62
20620505 2010
483
Significant association of appendiceal neoplasms and ulcerative colitis rather than Crohn's disease. 62
19705419 2010
484
Clinical characteristics and prognostic factors for primary appendiceal carcinoma. 62
20398034 2010
485
How should we treat mucinous appendiceal neoplasm? By laparoscopy or laparotomy? A case report. 62
20514834 2010
486
Evaluation of the cost-effectiveness of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (peritonectomy) at the St George Hospital peritoneal surface malignancy program. 62
20040853 2010
487
Bladder metastases of appendiceal mucinous adenocarcinoma: a case presentation. 62
20178637 2010
488
Modern systemic chemotherapy in surgically unresectable neoplasms of appendiceal origin: a single-institution experience. 62
19904805 2010
489
Appendiceal mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. 62
19641451 2009
490
Complete cytoreduction offers longterm survival in patients with peritoneal carcinomatosis from appendiceal tumors of unfavorable histology. 62
19717034 2009
491
Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin C. 62
19475451 2009
492
Primary appendiceal tumors: report on 10 cases. 62
20187516 2009
493
Incidental cystadenocarcinoma of the appendix in a patient undergoing laparoscopic right hemicolectomy for caecal cancer: a case report. 62
19829982 2009
494
Diverticulosis and diverticulitis of the appendix. 62
19233860 2009
495
Incidence of synchronous appendiceal neoplasm in patients with colorectal cancer and its clinical significance. 62
19490638 2009
496
Epithelial appendiceal neoplasms. 62
19556909 2009
497
Significance of FDG-PET in Identification of Diseases of the Appendix - Based on Experience of Two Cases Falsely Positive for FDG Accumulation. 62
20651978 2009
498
Appendiceal mucinous cystadenoma is a neoplastic complication of IBD: case-control study of primary appendiceal neoplasms. 62
18989894 2009
499
Signet ring cell carcinoma of the appendix manifesting as colonic obstruction and ovarian tumors: report of a case. 62
19280284 2009
500
Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. 62
19133112 2009
501
Diverticular disease of the vermiform appendix: a diagnostic clue to underlying appendiceal neoplasm. 62
18715614 2008
502
Treatment of appendiceal adenocarcinoma in the United States: penetration and outcomes of current guidelines. 62
19062662 2008
503
Primary signet ring cell carcinoma of the appendix: a rare case report and our 18-year experience. 62
18837098 2008
504
Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. 62
18685490 2008
505
Treatment failure following complete cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal dissemination from colorectal or appendiceal mucinous neoplasms. 62
18726900 2008
506
The porta hepatis as a site of recurrence of mucinous appendiceal neoplasms treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy. 62
19112943 2008
507
Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings. 62
18287436 2008
508
Aggressive surgical management of peritoneal carcinomatosis with low mortality in a high-volume tertiary cancer center. 62
18080166 2008
509
Diagnostic limitations of 10 mm thickness single-slice computed tomography for patients with suspected appendicitis. 62
18301980 2008
510
Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. 62
17524597 2008
511
Survival and health outcomes after cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of appendiceal origin. 62
18030535 2008
512
Peritoneal dissemination of non-carcinoid primary appendiceal cancer. 62
17765296 2007
513
Malignant neoplasms of the appendix. 62
17447078 2007
514
From Krukenberg to today: the ever present problems posed by metastatic tumors in the ovary. Part II. 62
17452813 2007
515
Synchronous appendiceal tumours. 62
17450695 2007
516
Surgical treatment of malignant carcinoid tumours of the appendix. 62
16911574 2007
517
Primary appendiceal cancer: gynecologic manifestations and treatment options. 62
17055559 2007
518
Early results of surgery in 123 patients with pseudomyxoma peritonei from a perforated appendiceal neoplasm. 62
17115339 2007
519
Role of appendectomy at the time of primary surgery in patients with early-stage ovarian cancer. 62
16806436 2006
520
Primary appendiceal malignancy: a clinicopathologic study. 62
17116623 2006
521
Management of goblet cell carcinoid. 62
16967437 2006
522
From krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part I. Historical perspective, general principles, mucinous tumors including the krukenberg tumor. 62
16998315 2006
523
The natural history, gross pathology, and histopathology of appendiceal epithelial neoplasms. 62
16621426 2006
524
Appendiceal cancer and peritoneal carcinomatosis: a report of 29 cases. 62
16913315 2006
525
Management of an unexpected appendiceal neoplasm. 62
16775823 2006
526
The "alphabet soup" of peritoneal dissemination from appendiceal neoplasms and other malignancies. 62
16538404 2006
527
Appendiceal neoplasms with peritoneal dissemination: outcomes after cytoreductive surgery and intraperitoneal hyperthermic chemotherapy. 62
16538401 2006
528
Perioperative intraperitoneal chemotherapy for peritoneal surface malignancy. 62
16606461 2006
529
Review of patients with peritoneal malignancy treated with peritonectomy and heated intraperitoneal chemotherapy. 62
16626358 2006
530
Appendix adenocarcinoma associated with ulcerative colitis: a case report and literature review. 62
16528481 2006
531
Reconstruction of urinary tract combined with surgical management of locally advanced non-urological cancer involving the genitourinary organs. 62
16401927 2006
532
An eight-year survivor with multiple brain metastases of non-small cell lung cancer: an autopsy case. 62
16739328 2006
533
New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? 62
16389186 2006
534
[Microhematuria secondary to mucocele and appendicular cystoadenoma]. 62
16393627 2006
535
Immunohistochemical expressions of cytokeratins, mucin core proteins, p53, and neuroendocrine cell markers in epithelial neoplasm of appendix. 62
16260276 2005
536
[Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy]. 62
16318097 2005
537
[Appendiceal mucinous cystadenoma]. 62
15702149 2005
538
Ureteral metastasis from appendiceal cancer: report of a case. 62
15674503 2005
539
Carcinoid tumors of the appendix. Prognostic factors and evaluation of indications for right hemicolectomy. 62
15783011 2005
540
Incidence and predictors of appendiceal tumors in elderly males presenting with signs and symptoms of acute appendicitis. 62
15546558 2004
541
Synchronous extraperitoneal and intraperitoneal dissemination of appendix cancer. 62
15336733 2004
542
Appendix tumors in the era of laparoscopic appendectomy. 62
15156378 2004
543
Pseudomyxoma peritonei and selected other aspects of the spread of appendiceal neoplasms. 62
15807473 2004
544
Primary neoplasms of the appendix: radiologic spectrum of disease with pathologic correlation. 62
12740466 2003
545
Expression of mucins and cytokeratins in primary carcinomas of the digestive system. 62
12748245 2003
546
Mucinous cystadenocarcinoma of the appendix. The controversy persists: a review. 62
12749241 2003
547
Appendiceal carcinoids in Crohn's disease. 62
12560854 2003
548
[Pseudomyxoma peritonei: report of 11 cases with a literature review]. 62
12622904 2002
549
Appendix cancer mimicking ovarian cancer. 62
12445258 2002
550
Cancer of appendix as a presenting feature of Crohn's disease. 62
12352226 2002
551
Primary neoplasms of the appendix manifesting as acute appendicitis: CT findings with pathologic comparison. 62
12202713 2002
552
Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. 62
12115365 2002
553
Diseases of the appendix recognized during colonoscopy. 62
19861790 2002
554
First documented case of Aeromonas veronii biovar sobria infection in northern Europe. 62
12030401 2002
555
Pseudomyxoma peritonei of appendiceal cancer with metastasis to the stomach: report of a case. 62
12107784 2002
556
Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. 62
11776492 2001
557
Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients. 62
11505065 2001
558
Gelatinous ascites: a cytohistologic study of pseudomyxoma peritonei in 67 patients. 62
11454998 2001
559
Krukenberg tumor from an occult appendiceal adenocarcinoid: a case report and review of the literature. 62
11435017 2001
560
Epithelial cells and other cytologic features of pseudomyxoma peritonei in patients with ovarian and/or appendiceal mucinous neoplasms: a study of 12 patients including 5 men. 62
10692212 2000
561
Acidic glycosaminoglycans of abdominal mucin in a case of pseudomyxoma peritonei caused by appendiceal cancer. 62
10573367 1999
562
Primary appendiceal adenocarcinoma. 62
10521058 1999
563
K-ras and p53 mutations in the pathogenesis of classical and goblet cell carcinoids of the appendix. 62
10391558 1999
564
Goblet-cell mucinous epithelium lining the endometrium and endocervix: evidence of metastasis from an appendiceal primary tumor through the use of cytokeratin-7 and -20 immunostains. 62
9785138 1998
565
Femoral neuropathy: unusual presentation for recurrent large-bowel cancer. 62
9678379 1998
566
The use of laparoscopy in a case of appendiceal cystadenoma presenting as pseudomyxoma peritonei in an inguinal hernial sac. 62
9621537 1998
567
[The appendix cancer complicated by carcinomatous tumor of the abdominal organs]. 62
9787580 1998
568
Cancer of the appendix in long-standing ulcerative colitis: a case report. 62
9526592 1997
569
Primary adenocarcinoma of appendix, colonic type associated with perforating peritonitis in an elderly patient. 62
9349993 1997
570
Treatment of peritoneal carcinomatosis from colon or appendiceal cancer with induction intraperitoneal chemotherapy. 62
8849959 1996
571
Prognostic features for peritoneal carcinomatosis in colorectal and appendiceal cancer patients when treated by cytoreductive surgery and intraperitoneal chemotherapy. 62
8834578 1996
572
Prognostic implications of chemoresistance-sensitivity assays for colorectal and appendiceal cancer. 62
7572768 1995
573
Expression of cytokeratin 7 in simultaneous mucinous tumors of the ovary and appendix. 62
7545815 1995
574
Patient selection and treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer. 62
7754629 1995
575
Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. 62
7857141 1995
576
Laparoscopic management of appendiceal intussusception associated with villous adenocarcinoma. 62
7833525 1994
577
A case of appendiceal cancer metastatic to the stomach with pseudomyxoma peritonei. 62
7515309 1994
578
Primary appendiceal neoplasms. 62
8270409 1993
579
Peritoneal carcinomatosis from appendiceal cancer: results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy. 62
8458256 1993
580
Primary appendiceal malignancies: rare but important. 62
1542852 1992
581
[Appendix cancer]. 62
2156395 1990
582
[A resected case of metastatic lung cancer after curative operation in appendiceal cancer]. 62
2541271 1989
583
[Appendiceal cancer. Clinico-therapeutic aspects]. 62
2971246 1988
584
Mucinous adenocarcinoma of the appendix presenting as an ovarian cystadenocarcinoma: case report and review of appendiceal neoplasms with ovarian metastases. 62
3023143 1986
585
Adenocarcinoid of the appendix presenting as bilateral Krukenberg's tumor of the ovaries. Immunohistochemical and ultrastructural studies and literature review. 62
2994592 1985
586
[Primary appendiceal cancer]. 62
6645896 1983
587
Adenocarcinoma of the colon associated with benign appendiceal neoplasm. 62
7089665 1982
588
[Appendiceal neoplasm resulting from a malignant transformation of a villous adenoma]. 62
7460688 1980
589
Appendiceal carcinoma mimicking primary bladder cancer. 62
6245280 1980
590
[The primary appendix neoplasm]. 62
763116 1979
591
Pseudomyxoma peritonei et ovarii with an occult neoplasm of appendix: case report. 62
683699 1978
592
[Primary appendiceal cancer]. 62
4460667 1974
593
[Primary appendiceal cancer (apropos of an anatomo-clinical case)]. 62
5503856 1970

Variations for Appendiceal Neoplasm

Expression for Appendiceal Neoplasm

Search GEO for disease gene expression data for Appendiceal Neoplasm.

Pathways for Appendiceal Neoplasm

Pathways related to Appendiceal Neoplasm according to GeneCards Suite gene sharing:

(showing 18, show less)
# Super pathways Score Top Affiliating Genes
1
Show member pathways
11.87 KRAS HRAS CEACAM5
2
Show member pathways
11.71 KRAS HRAS GNAS
3
Show member pathways
11.49 KRAS HRAS GNAS
4 11.38 KRAS HRAS CHGA
5
Show member pathways
11.18 KRAS HRAS GNAS
6 11.13 KRAS HRAS
7
Show member pathways
11.07 KRAS HRAS
8 11.03 KRAS HRAS
9 11.02 KRAS HRAS
10
Show member pathways
11 KRAS HRAS
11 10.97 KRAS HRAS
12 10.94 KRAS HRAS
13
Show member pathways
10.93 KRAS HRAS
14 10.84 KRAS HRAS
15 10.76 HRAS KRAS
16 10.73 HRAS KRAS
17
Show member pathways
10.58 KRAS HRAS GNAS
18
Show member pathways
10.4 KRAS HRAS

GO Terms for Appendiceal Neoplasm

Biological processes related to Appendiceal Neoplasm according to GeneCards Suite gene sharing:

(showing 1, show less)
# Name GO ID Score Top Affiliating Genes
1 regulation of long-term neuronal synaptic plasticity GO:0048169 8.92 KRAS HRAS

Sources for Appendiceal Neoplasm

2 CDC
6 CNVD
8 Cosmic
9 dbSNP
10 DGIdb
16 EFO
17 ExPASy
18 FMA
19 GARD
27 GO
28 GTR
29 HMDB
30 HPO
31 ICD10
32 ICD10 via Orphanet
33 ICD11
34 ICD9CM
35 IUPHAR
36 LifeMap
38 LOVD
40 MedGen
43 MeSH
44 MESH via Orphanet
45 MGI
48 NCI
49 NCIt
50 NDF-RT
52 NINDS
53 Novoseek
55 ODiseA
56 OMIM via Orphanet
57 OMIM® (Updated 08-Dec-2022)
61 PubChem
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 Tocris
71 UMLS
72 UMLS via Orphanet
Content
Loading form....